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Burkholderia pseudomallei is an intracellular pathogen that causes a severe disease known as 
melioidosis affecting both animals and humans in South East Asia and Northern Australia. B. 
pseudomallei displays actin-based motility in the cytoplasm of infected cells, although its mechanism 
is largely unknown. Located at the pole of the bacterium is BimA which is vital for motility, survival 
and virulence. BimA interacts with actin and initiates the formation of actin tails independently of the 
Arp 2/3 complex. Listeria monocytogenes actin-based motility has been shown to be affected by the 
host cell enzyme Casein Kinase II. This enzyme phosphorylates the bacterial factor ActA which is 
required for L. monocytogenes intracellular motility. My project aims to investigate the effect of 
phosphorylation of BimA on actin-based motility in B. pseudomallei. Online prediction tools were used 
to perform a bioinformatics analysis of BimA and identify potential phosphorylation sites. Actual 
phosphorylation sites were identified by mass spectrometry analysis of ectopically expressed BimA 
protein in HeLa cells and from in vitro kinase assays on recombinant GST-BimA protein. BimA 
phosphorylation mutant proteins were generated and expressed in a bimA mutant. Analysis of 





















Burkholderia pseudomallei is a bacterium that is able to invade and replicate inside the host cell. It 
causes a severe disease known as melioidosis affecting both animals and humans in South East Asia 
and Northern Australia. B. pseudomallei is able to use host cell actin to form a tail behind it and power 
movement inside the cell. This process is called actin-based motility and the mechanism is largely 
unknown. Located at the pole of the bacterium is a bacterial factor known as BimA which is vital for 
motility and survival. BimA interacts with actin and initiates the formation of actin tails. Listeria 
monocytogenes is another bacteria that utilises actin-based motility to promote movement in the host 
cell. It has been shown to be affected by the host cell enzyme Casein Kinase II. This enzyme 
phosphorylates the actin-based motility factor ActA in Listeria. My project aims to investigate the 
effect of phosphorylation of BimA on actin-based motility in B. pseudomallei. Analysis of 
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Chapter 1: Introduction 
Certain intracellular bacterial pathogens have developed unique mechanisms to invade host cells by 
utilising the host cell actin (reviewed in Stevens et al. 2006). Once inside the cell the bacteria needs to 
escape the endosome first before it can rapidly polymerise actin leading to the formation of actin-rich 
tails and movement within the cytoplasm. This process is known as actin-based motility and leads to 
the formation of membrane protrusions, allowing entry into adjacent cells and cell to cell spread 
(Monach and Theriot 2001) (Kespichayawattana et al. 2000). Certain species of Listeria, Rickettsia, 
Burkholderia, Shigella and Mycobacterium are able to exploit host cell actin polymerisation pathways 
to avoid the adaptive immune system and remain undetected, thereby promoting their own survival. 
There are many different actin polymerisation pathways in the host cell and each bacterium has 
evolved different factors to polymerise actin. The detailed molecular mechanisms underlying these 
processes are still not fully understood and are active areas of ongoing research. The polymerisation 
of actin by the host cell is often regulated by phosphorylation by cellular kinases. This project will study 
whether actin-based motility of B. pseudomallei is regulated by phosphorylation.  
 
Burkholderia pseudomallei 
Burkholderia pseudomallei  is a Gram negative bacterium that causes a severe disease known as 
melioidosis affecting both animals and humans in South East Asia and Northern Australia  (White 2003) 
(reviewed in Stevens and Stevens 2009). Sporadic cases have also been seen in the Middle East, China, 
India and South America.  B. pseudomallei is an environmental soil saprotype that is most likely to 
survive by obtaining nutrition from rotting organic matter or opportunistically from invasion of 
protozoa (reviewed in Lazar-Adler et al. 2009). B. pseudomallei is commonly found in wet and stagnant 
waters such as rice paddies with most cases occurring in people who are in regular contact with the 
soil (reviewed in Wiersinga et al. 2012). The number of cases increases during the rainy season 
because flooding increases the spread of the bacteria from its natural habitat (reviewed in Brett et al. 
2000). 
It is very rare for B. pseudomallei to be transmitted from person to person and so the routes of 
infection are by inhalation, ingestion or cutaneous inoculation of contaminated soil or water. The 
incubation period normally lasts between 1-21 days with typical symptoms including pneumonia and 
the formation of abscesses in internal organs such as the lungs or liver (reviewed in Wiersinga et al. 
2012). Melioidosis can display different forms of disease, the type of infection varying depending on 
the route of inoculation. B. pseudomallei can spread to internal organs such as the liver, spleen or 
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brain, or to the blood, resulting in septicaemia (reviewed in White, 2003). The mechanism of the 
secondary spread is not known but as the bacteria can invade and survive in macrophages they could 
be a potential transport vehicle via the lymphatic system (reviewed in Lazar-Adler et al. 2009). Acute 
localised infections occur from inoculation of abrasions in the skin resulting in fever, muscle soreness 
and skin abscesses which could lead to septicaemia. Pulmonary infections occur through inhalation 
causing mild bronchitis leading to severe pneumonia. Additionally, patients will also often suffer from 
high fever, headache and muscle soreness. This is followed by the appearance of abscesses in the 
lungs and death within a few days if left untreated (reviewed in Cheng et al. 2005). Often symptoms 
are associated with pre-disposing factors such as diabetes and alcoholism.  
The Burkholderia genus consists of 40 species and the closest genetic relatives to B. pseudomallei are 
Burkholderia mallei and Burkholderia thailandensis. B. mallei causes the disease glanders which 
primarily affects horses but can infect humans with high mortality. B. thailandensis is an avirulent soil 
saprophyte found in certain soil types in Thailand. B. thailandensis is similar to B. pseudomallei in that 
it can survive outside of the host in the soil whereas B. mallei cannot. B. mallei lacks the functional 
flagella seen in its genetic relatives and has not yet been isolated from a non-animal environment (Kim 
et al. 2005). B. thailandensis has been used as a model for B. pseudomallei in a number of studies as 
it contains a number of homologues such as known virulence factors and the Type 3 secretion system 
(Haraga et al. 2008) (Sarkar-Tyson et al. 2009). The advantage of using B. thailandensis as a model for 
B. pseudomallei is being able to perform research at containment level two as opposed to containment 
level three. 
B. pseudomallei is considered a schedule 5 bioterrorism agent by the UK government as it is 
transmitted by aerosol and has a very low infectious dose. It is resistant to many antibiotics including 
penicillin, quinolones and aminoglycosides and recommended treatment is a combination therapy of 
intravenous Ceftazidime or Meropenem for 14 days followed by oral Trimethoprim-sulfamethoxazole 
or Doxycycline for 3-6 months as there is no vaccine currently available (Moore et al. 1999) (Lipsitz et 
al. 2012). The intracellular life cycle of the bacterium makes it difficult for effective antibiotic 
treatment because the drug is needed to target the bacteria inside the host cell.   
 
B. pseudomallei life cycle 
B. pseudomallei is a motile pathogen that is able to invade both phagocytic and non-phagocytic cells. 
There are many stages to this infection process involving: Adhesion, Type 3 Secretion System-
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mediated cell entry or phagocytosis, escape from the vacuole, actin-based motility, and formation of 
multinucleated giant cells (Figure 1).  
 
Figure 1: Intracellular life of B. pseudomallei 
The intracellular life of B. pseudomallei: 1) Invasion 
of the host cell involves adhesins BoaA, BoaB and 
pilA for attachment before the T3SS is used to enter 
the cell. 2) Escape from the endosome uses the 
T3SS to release effectors to break down the 
endosome membrane. 3) Actin-based motility stage 
involves bacterial factor BimA to initiate formation 




Adhesion is the initial step in bacterial pathogenesis and the exact method of attachment is still 
unclear although it is thought to involve Type IV pili (Essex-Lopresti et al. 2005) (Reviewed in Galyov 
et al. 2010). These filaments and the proteins they contain are suggested to play a role in virulence. 
The PilA gene that encodes the pilin subunit protein was shown to be important for adhesion to the 
host cell (Essex-Lopresti et al. 2005) (Boddey et al. 2006). Adhesins BoaA and BoaB are also involved 
in this process (Balder et al. 2010) (reviewed in Allwood et al. 2011). The thin layer of polysaccharide 
around the bacteria known as the capsule has also been shown to be important for adhesion to 
epithelial cells (Ahmed et al. 1999).  
After attachment to the host cell B. pseudomallei can enter the cell either via phagocytosis or invasion.  
For invasion, a Type 3 Secretion System apparatus (T3SS) encoded by the bsa (Burkholderia secretion 
apparatus) locus is used to target host cell pathways (Stevens et al. 2002). The T3SS consists of around 
20 proteins that are assembled into a needle-like structure which injects bacterial proteins into the 
host cell. This structure allows the bacteria to secrete effector molecules into the host that can hijack 
cellular pathways. Some key proteins in the bsa locus are the structural proteins BipD (translocator), 
BsaQ (structural component), and BopE (effector) (reviewed in Sun and Gan 2010) (reviewed in 
Allwood et al. 2011). The BopE effector is a guanine nucleotide exchange factor that works by 
rearranging the host actin cytoskeleton for entry. A bopE mutant displayed reduced invasion of 
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epithelial cells (Stevens et al. 2003). A T3SS apparatus bipD mutant also exhibited an impairment in 
invasion, suggesting that more than one T3SS effector is involved in invasion (Stevens et al. 2003). 
Following uptake, the bacteria has to escape endocytic vacuoles (Stevens et al. 2002). This process is 
also thought to involve the T3SS, which releases effectors that break down vacuolar membranes of 
the phagosome and help promote escape into the cytosol (reviewed in Galyov et al. 2010).  Mutants 
within the T3SS demonstrate a defect in vacuolar escape, which results in a variety of effects, including 
reduced actin-tail formation, intracellular survival, cytotoxicity and intracellular spread (Stevens et al. 
2002) (Stevens et al. 2003).  
Invasion of both epithelial and macrophage cells by B. pseudomallei induces autophagy, a cellular 
process that allows the degradation and recycling of cellular components. It is a catabolic pathway 
that uses lysosomes to break down cellular components and forms an important part of the innate 
immune response. B. pseudomallei is able to successfully evade autophagy and the T3SS plays a role 
in this evasion. BopA, a T3SS effector protein, has been shown to be important for evading autophagy 
and efficient escape from the phagosome (Gong et al. 2011). BopA is thought to be involved in 
modulating the host cell response as a bopA mutant showed increased colocalization with 
microtubule-associated protein light chain 3 (LC3) and reduced intracellular survival (Cullinane et al. 
2008). LC3 is an autophagy marker protein that is recruited to phagosomes to stimulate killing of B. 
pseudomallei.  
Once inside the cell cytoplasm the bacterium is able to form actin comet tails and promote its own 
survival by a process known as actin-based motility. B. pseudomallei uses the protein BimA 
(Burkholderia intracellular motility factor A) to initiate the formation of actin tails in the cytosol 
(Stevens et al. 2005). BimA is a putative Type V secreted protein which is important for intracellular 
survival (Sitthidet et al. 2011), virulence (Lazar-Adler et al. 2015) and actin-based motility (Stevens et 
al. 2005 and unpublished data from the Stevens laboratory). A bimA mutant was shown to lack actin-
based motility but was able to invade the cell and escape from the vacuole (Stevens et al. 2005). The 
mechanism by which it recruits and activates factors to assemble actin is still being researched, 
however it is known that BimA directly binds with actin and can stimulate its polymerisation in vitro 
(Stevens 2005). BimA has been recently suggested to mimic Ena/Vasp proteins in the elongation of 
actin tails (Benanti et al. 2015). Like other bacterial factors involved in actin-based motility it is located 
at the pole of a single daughter cell. It is likely a trimeric protein which improves its stability against 
proteases (Benanti et al. 2015). 
B. pseudomallei is able to use a Type 6 Secretion System (T6SS) to deliver effectors that enhance its 
ability to replicate. A T6SS effector protein mutant (hcp) showed slightly reduced actin-based motility 
5 
 
compare to the wildtype (Burtnick et al. 2010). Actin-based motility results in the formation of 
membrane protrusions into adjacent cells and leads to multinucleated giant cell formation. The T6SS 
is also involved in this process where the protein VgrG-5 has been shown to be important for 
membrane fusion (Schwarz et al. 2014) (Toesca et al. 2014). This multinucleated giant cell formation 
is unique to Burkholderia and has not been seen in other intracellular bacteria.  
 
Host cell actin nucleation and polymerisation 
Actin is one of the most abundant proteins in the cell and a major component of the cytoskeleton. It 
provides the roadways for proteins resulting in many processes such as: cell motility, cell adhesion, 
phagocytosis and cell division. The cytoskeleton is a highly dynamic environment with rapid assembly 
and disassembly of actin filaments in the cell. Actin has two forms; G-actin which is ATP-bound and F-
actin which is ADP-bound. The G-actin is assembled to form a filament of F-actin which has a fast 
growing barbed end and a slow growing pointed end (reviewed in Firat-Karalar et al. 2011) (Figure 2). 
Polymerisation of actin filaments requires ATP hydrolysis and this process is regulated by actin-binding 
proteins. The stimulation of actin polymerization drives many essential cellular processes, including 
cell migration. 
In eukaryotic cells the initial nucleation of actin requires actin-nucleating proteins. These fall into three 
groups: Actin-related protein 2/3 complex (Arp 2/3) and Nucleation promoting factors (NPFs), formins 
and tandem-monomer-binding nucleators (reviewed in Firat-Karalar et al. 2011). The different 
mechanisms of nucleation are shown in Figure 2.  
The Arp 2/3 complex initiates and nucleates the growth of actin filaments. It is a conserved ubiquitous 
complex of seven polypeptides comprising actin-related proteins Arp2 and Arp3. Wiskott-Aldrich 
syndrome protein (WASP) and other NPFs regulate the activity of Arp 2/3 (reviewed in Campellone et 
al. 2010). The components of the Arp 2/3 complex directly bind to actin after activation by an NPF. 
Host cell nucleation-promoting factors bind and activate the Arp2/3 complex through the C and A 
regions of their VCA domain (reviewed in Goley and Welch 2006). NPFs are needed to activate the 
Arp2/3 complex which then nucleates the formation of new filaments that extend from the sides of 
existing filaments at a 70 degree angle to form a Y-branched network (reviewed in Goley and Welch 
2006). WASP and N-WASP are multidomain proteins that help regulate the actin cytoskeleton. They 
contain small GTPase-binding domains which interact with Cdc42, a Rho GTPase. They also contain a 




Tandem-monomer-binding nucleators contain tandem G actin-binding motifs, which bring together 
monomers to form a polymerisation nucleus (reviewed in Chesarone et al. 2009). Spir, Cordon bleu 
and Leiomodin are all examples and contain actin monomer-binding WASP- homology 2 (WH2) 
domains (reviewed in Chesarone et al. 2009) (reviewed in Paunola et al. 2012). These nucleators 
stimulate polymerisation of an unbranched filament.  
Formins are multidomain proteins that function as dimers to assemble straight unbranched actin 
filaments (reviewed in Chesarone et al. 2009). Formins nucleate actin and act as elongation factors for 
growing actin filaments. They use their doughnut-shaped domains to crown the barbed end and 
progressively move with the growing filament end (reviewed in Chesarone et al. 2009). Another 
elongation factor that has been characterised is Enabled/vasodilator-stimulated phosphoprotein 
(Ena/ VASP). Like formins, Ena/VASP proteins bind to actin and move with the growing filament, but 
form tetramers rather than dimers. They are able to group and elongate two filaments at once 
(Winkleman et al. 2014).  
 
Figure 2: Nucleation of actin 
Diagram showing the three main classes 
of protein that have been identified to 
nucleate actin by a distinct mechanism. 
NPFs work with the Arp 2/3 complex to 
form branched actin filaments from 
monomers. Tandem-monomer-binding 
nucleators function as a scaffold for 
polymerisation to generate an 
unbranched filament. Formins attach to 
the end of the actin and move along with 
the growing filament. (Adapted from 
Goley et al. 2006).  
 
After nucleation the filaments grow freely at their barbed ends until there is a lower level of monomers 
or capping proteins terminate elongation. Elongation factors are able to promote the growth of 
filaments whereas capping proteins limit the growth by binding to the barbed end of an actin filament 
and blocking the addition or removal of actin subunits (reviewed in Edwards et al. 2014).  
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Severing existing filaments into multiple smaller ones can generate new ends. Actin-binding proteins 
such as Actin Depolymerising factor (ADF)/cofilin promote this debranching and depolymerisation to 
generate a new pool of monomers. Rho-family GTPases activate p21-Activated Kinase (PAK) and LIM-
1 kinase, which in turn phosphorylate ADF/cofilin. This slows down the turnover of the filaments by 
inhibition of ADF/cofilin (Pollard et al. 2003). Actin monomers are then nucleated again by the Arp 2/3 
complex to complete the cycle of actin assembly in the eukaryotic cell. 
The whole process of actin nucleation and polymerisation is a dynamic and changing environment that 
needs to be regulated by the cell. Phosphorylation of actin-binding proteins by host cell kinases is a 
key modification that helps to achieve this. For example, Cortactin is an actin-binding protein enriched 
in lamellipodia of motile cells, that has been shown to be phosphorylated by Protein Kinase D (PKD) 
and Pak1 kinases (Eiseler et al. 2010) (Grassart et al. 2010). Phosphorylation of Cortactin by these 
kinases regulated the interaction of N-WASP proteins with Arp 2/3 and it’s activation. Additionally 
WASP proteins have been shown to be phosphorylated by many host cell kinases. Phosphorylation of 
Serine residues in WASP by Casein Kinase 2 (CK2) increased the affinity for Arp 2/3 complex (Cory et 
al. 2003). Tyrosine residues of WASP proteins have also been shown to be phosphorylated by activated 
Cdc42-associated kinase-1 (Ack1) and Proto-oncogene tyrosine-protein (Src) family kinases which 
enhanced actin polymerisation in vitro (Yokoyama et al. 2005) (Cory et al. 2002). Furthermore, Formin 
proteins can be activated by phosphorylation to form actin-based structures called stress fibres. The 
Formin homology domain protein 1 (FHOD1) has been shown to be phosphorylated by Rho-dependent 
protein kinase (ROCK) to activate the formation of stress fibres (Takeya et al. 2008).  
 
Actin-based motility of pathogens 
Many intracellular pathogens are able to use actin-based motility to move within and between cells 
and display speeds between 3 to 87 µm per minute depending on the host cell type (reviewed in 
Stevens et al. 2006). They are able to interfere with the host cell actin structure by reorganizing it for 
movement inside the cell which leads to the formation of an actin tail at one pole of the bacterium. 
These tails are made up of growing actin filaments that propel the bacterium through the cytosol at 
high speed. The actin does not move with the bacterium but is fixed in the cytosol and depolymerizes 
at a constant rate. Therefore the length of the actin tail is proportional to the rate at which the 
bacterium is moving (reviewed in Stevens et al. 2006).  
Most pathogens that utilise actin-based motility rely on the cellular Arp 2/3 complex. The organisation 
and distribution of actin filaments is determined by nucleation and elongation factors such as Arp2/3 
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complex and NPFs that assemble actin networks.  Bacteria are able to exploit this mechanism for their 
own benefit where they mimic host cell WASP or recruit WASP to the bacterial pole (reviewed in 
Stevens et al. 2006).  Activation of Arp 2/3 leads to a conformational change initiating the formation 
of new actin filaments and generates a branched actin network which forms the actin tail (Amann and 
Pollard 2001, Gouin et al. 2004). Bacteria can form comet tails that consist of either branched or 
unbranched actin filaments. Many of the bacterial factors that are necessary for intracellular motility 
are expressed at the pole of the bacterium from which the actin-rich tail forms. Two known 
mechanisms of actin-based motility deployed by intracellular pathogens using the Arp 2/3 complex 
are shown in Figure 3. 
 
Figure 3: Arp 2/3-dependent actin-based motility of intracellular pathogens 
Mechanisms by which intracellular pathogens 
recruit and activate Arp2/3-dependent actin 
polymerization at the bacterial pole of the 
cell. Bacterial factors in Listeria and Rickettsia, 
ActA and RickA, are able to mimic Nucleation-
promoting factors and bind directly to Arp  2/3 
complex. In contrast Shigella employs a 
bacterial factor, IcsA that requires 
recruitment of N-WASP to bind to Arp 2/3 
complex. (From Stevens et al. 2006) 
 
Shigella flexneri 
Shigella is a Gram negative bacterium that infects the intestinal epithelium, causing a diarrhoeal 
disease called shigellosis. It is a member of the group of pathogens that use actin-based motility to 
spread between cells. The bacterial factor IcsA is an autotransporter protein and a major virulence 
factor in the bacterium (May et al. 2012) (Sansonetti et al. 1991). IcsA is located at the pole of the 
outer membrane, where it orchestrates the actin polymerisation necessary for actin-based motility 
and cell spreading. IcsA interacts indirectly with the Arp 2/3 complex by recruiting N-WASP proteins 
to bind to the Arp 2/3 complex (reviewed in Welch et al.  2013).This links signalling pathways and aids 
in the de novo polymerisation of actin to start the formation of the actin tail (Suzuki et al. 1998).  
IcsA belongs to a family of virulence-associated auto-secreted proteins of Gram negative bacteria. 
Autotransporters are proteins that have been translocated by the Type V secretion pathway in Gram 
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negative bacteria.  Autotransporters can display many different functions and act as invasins, 
adhesins, proteases, or actin-nucleating factors (reviewed in Lazar-Adler et al. 2011). Autotransporter 
proteins are found in many Gram negative bacteria and have many functional domains. They include 
an N-terminal signal peptide, an internal passenger domain, and a C-terminal membrane anchor 
domain (reviewed in Cotter et al. 2005). 
Host cell kinases play important roles in the stages of cell invasion by Shigella. They are known to have 
a role in bacterial cell entry and more recently in actin-based motility. Burton tyrosine kinase (Btk) 
depletion in Shigella-infected cells led to a decrease in N-WASP phosphorylation which affected the 
N-WASP recruitment to the bacterial surface and decreased actin-based motility (Dragoi et al. 2013). 
Host cell Abl kinases are also required for actin tail formation and motility. These kinases have been 
shown to phosphorylate N-WASP and help regulate actin tail formation and are important to the 
intracellular motility of Shigella (Burton et al. 2005).  
 
Mycobacterium marinum 
The Gram-positive bacterium M. marinum causes a systemic tuberculosis-like disease in fish and 
amphibians. It also causes pulmonary and cutaneous lesions in humans. It replicates inside 
macrophages, escapes into the cytosol and is able to actively polymerise actin (Stamm et al. 2003). 
Actin tails normally appear 15 hrs after infection and motility is dependent upon host WASP family 
proteins (Stamm et al. 2005). Inhibition of both WASP and N-WASP lead to incomplete actin 
polymerisation (Stamm et al.2005).  Actin-based motility occurs independently of known N-WASP 
activators such as Nck, and Cdc42 (Stamm et al. 2005). However little is known about the mechanism 
behind actin-based motility for Mycobacterium as a bacterial factor has yet to be identified.  
 
Rickettsia 
Rickettsia species are intracellular Gram negative bacteria that are responsible for a number of serious 
human diseases, including typhus and a variety of spotted fevers. Actin-based motility however is only 
seen in R. conorii and R. rickettsia which cause spotted fevers.  
Rickettsia contains two bacterial factors that enable it to display different actin-based motility for 
different stages of infection. Initial motility is slow and uses the RickA protein whereas late motility 
involves Surface cell antigen 2 (Sca2) which is much faster due to the protein mimicking host formins 
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(Reed et al. 2014). RickA assembles branched actin networks and Sca2 assembles unbranched 
networks (Haglund et al. 2010) (Figure 4). For some strains of Rickettsia they only have Sca2 or RickA.  
Sca2 is a bacterial actin-assembly factor that functionally mimics eukaryotic formin proteins, 
polymerising actin in an Arp 2/3-independent manner. Sca2 nucleates unbranched actin filaments 
which then polymerise and elongate into a tail (Haglund et al. 2010). The tails are seen to be long and 
straight rather than branched when deploying RickA (reviewed in Alberts and Way 2011). RickA mimics 
Nucleation-promoting factors and binds directly to Arp 2/3 complex to initiate the formation of an 
actin tail. 
 
Figure 4: Sca2 and RickA mediated tails 
Diagram showing the two bacterial factors deployed by 
Rickettsia to form an actin tail. RickA mimics NPFs to bind 
directly to the Arp 2/3 complex and form branched 
networks. Sca2 mimics formin proteins to elongate 





Listeria is a rare foodborne pathogen that infects the intestinal mucosa and causes the disease 
Listeriosis. The bacterial factor ActA is able to mimic NPFs to recruit the important proteins of the actin 
machinery (Welch et al. 1998). It displays structural similarity with the VCA domain of other WASP 
proteins where the Arp 2/3 complex can bind (Zalevsky et al. 2001). The central region of ActA has 
four proline-rich repeats that contain FPPPP or FPPIP motifs. These mimic host cell cytoskeletal 
proteins zyxin, vinculin and palladin. The proline-rich sequences in these proteins, as well as ActA, bind 
to proteins of the Ena-VASP family which can then stimulate profilin (Witke 2004). These are small 
actin-binding proteins found in all cells that control the direction of actin networks and their rate of 
polymerisation (Auerbach et al. 2003).  
ActA has been shown to be targeted by host cell Casein kinase 2 (CK2) which phosphorylates the 
WASP-binding region of Arp 2/3 on ActA (Chong et al. 2009). Studies on Listeria monocytogenes have 
shown that inhibition of CK2 reduced actin-based motility, raising the possibility that phosphorylation 
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plays a key role in this function (Chong et al. 2009). CK2 is an enzyme that phosphorylates Serines and 
Threonines. There are more than 300 cellular substrates that are ubiquitous and described for CK2 
including: signalling proteins, transcription factors and cytoskeletal structural proteins. CK2 is a 
tetrameric enzyme displaying 2 redundant catalytic sub-units, CSNK2A1 and CSNK2A2, and two 
regulatory subunits, CSNK2B. Individual removal of these subunits showed no effect but both together 
showed it is required for L. monocytogenes cell to cell spread (Chong et al. 2011). The role of CK2 in 
Listeria actin-based motility was confirmed by an independent RNAi screen for kinases involved in 
Listeria actin-based motility (Chong et al. 2011).  
Interestingly, in the same study Casein Kinase 1 (CK1) was shown to be dispensable for actin-based 
motility, but CK1 depletion showed a decrease in membrane protrusions into adjacent cells (Chong et 
al. 2011). Phosphorylation of the Arp 2/3 binding domain in ActA is regulated by CK2. It was shown to 
be vital for actin tail formation because the Arp2/3 complex did not co-localize with the bacteria and 
form tails in CK2-depleted cells (Chong et al. 2009). It is possible that a region of the BimA protein in 
B. pseudomallei, which is required for B. pseudomallei actin-based motility, may also be targeted by 
CK2 or other host cell kinases which could have a key role in controlling actin-based motility. 
 
Vaccinia Virus 
A close relative of the agent of smallpox (Variola virus) is the Vaccinia virus. It has been shown to use 
host cell actin for cell to cell spread of the virus. The virus is able to mimic receptor tyrosine kinase 
signalling pathways that control actin polymerisation at the plasma membrane. Phosphorylation of 
the viral protein A36R at tyrosine 112 and 132 are key to this motility as this results in direct interaction 
with the adaptor protein Nck and recruitment of N-WASP to the site of actin assembly stimulating Arp 
2/3 (Frischknecht et al. 1999).  
CK2 has been shown to also be important to Vaccinia actin-based motility where depletion of the 
enzyme impaired actin tail formation (Alvarez et al. 2012). It is possible that CK2 may stimulate 
adaptor protein recruitment potentionally through A36 phosphorylation.  
 
Enteropathogenic Escherichia coli 
Enteropathogenic Escherichia coli (EPEC) is a Gram negative bacterium that causes diarrhoea in 
humans as a result of infection in the small intestine. Attachment is followed by the formation of actin 
pedestals beneath the bacteria. EPEC use Type 3 secretion machinery to translocate the receptor 
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protein Tir (translocate intimin receptor), allowing it to link the bacterium to the actin cytoskeleton of 
the host cell (Kenny et al. 1997a). A Type 3 secreted effector protein Tccp (Tir cytoskeleton coupling 
protein) is required for Tir to mediate actin accumulation. Tccp binds to N-WASP which stimulates 
Arp2/3 resulting in polymerisation of actin.   
Studies have shown that for actin assembly in EPEC, Tir requires phosphorylation of a tyrosine residue 
in the cytosolic C-terminal domain by phospholipase C-γ1 (Kenny et al. 1997b). Interestingly for a 
closely related species Enterohaemorrhagic Escherichia coli EHEC, the phosphorylation of the Tir 
protein is not required for actin assembly (Kenny et al. 1999).  
 
Chlamydia trachomatis 
Chlamydia is a Gram-negative intracellular bacterium which causes eye and genital disease. It is the 
most prevalent sexually transmitted bacterial pathogen in the western world. Chlamydia initiate their 
developmental life cycle once they have actively gained entry into host cells. The bacterium uses the 
T3SS to inject the translocated actin recruiting phosphoprotein (Tarp) into the cytosol. Actin is then 
recruited by Tarp to the attachment site and polymerised to allow entry. This is an example of a 
bacterial actin-binding protein that mediates invasion rather than actin-based motility. Studies have 
shown that phosphorylation of tyrosine residues in Tarp by Src and Ab1 family kinases had no effect 
on bacterial entry into host cells (Mehlitz et al. 2008) (Jewett et al. 2008).  
 
B. pseudomallei actin-based motility 
B. pseudomallei is different from other bacteria as it does not express an actin mediator that mimics 
Nuclear Promotion Factors to initiate Arp 2/3 activity. The Arp 2/3 complex has been shown to be on 
the pole of B. pseudomallei during actin-based motility but N-WASP proteins were not important for 
actin polymerisation (Breitbach et al. 2003). Work from the Stevens lab indicates that B. pseudomallei 
BimA polymerises actin in vitro independently of the Arp 2/3 complex (Stevens et al. 2005). A recent 
BimC paper shows that B. pseudomallei actin-based motility is not inhibited by Arp2/3 inhibitors (Lu 
et al. 2014). This therefore means that the bacterium is likely to display a unique mechanism of actin-
based motility that is different from other intracellular pathogens.  Recent studies have shown that 
BimA mimics host Ena/VASP proteins in nucleating and elongating actin filaments (Benanti et al. 2015). 
They showed that BimA mediated the elongation of 2/3 actin filaments and was able to remove 
capping proteins.   
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The mechanism of the polar targeting of the bacterial factor BimA is unknown. However, a recent 
screen has revealed a gene bimC (Burkholderia intracellular motility factor C), directly upstream of the 
bimA gene, that is required for actin tail formation by B. thailandensis (Lu et al. 2015). Deletion of 
bimC resulted in an even spread of BimA over the bacterial surface suggesting its potential role in 
polar targeting (Lu et al. 2015). A bimC mutant failed to show actin tails and motility but further studies 
are needed to investigate the effect on survival and virulence.  In B. thailandensis bimC acts as an iron-
binding protein and has been shown to interact with the transmembrane domain of bimA in an iron-
dependent manner (Lu et al. 2015). bimC encodes a glycotransferase which could affect actin-based 
motility by glycosylation of proteins.   
The Burkholderia species display different mechanisms of actin-based motility. In B. thailandensis the 
motility is Arp 2/3 dependent and nucleates branched filaments (Sitthidet et al. 2010) (Benanti et al. 
2015). In contrast, in B. pseudomallei and B. mallei motility, BimA independently nucleates 
unbranched filaments (Benanti et al. 2015).  The tail structure also differs between the species, as B. 
thailandensis actin tails are curved and dense whereas B. pseudomallei tails are longer and straighter, 
shown in Figure 5.   
 
Figure 5: Different mechanisms of actin-based motility in Burkholderia 
Diagram displaying the different 
mechanisms and tail structure 
amongst the Burkholderia 
species. B. thailandensis 
activates host Arp 2/3 complex 
to assemble branched actin 
networks. B. pseudomallei and 
B. mallei mimic Ena/VASP 
proteins to form unbranched 
networks in an Arp 2/3-
independent manner.  (From 
Benanti et al. 2015).  
 
Distinct differences have been seen in the BimA protein among the closely related Burkholderia 
species as shown in Figure 6. B. thailandensis is different to B. pseudomallei in that BimAth contains a 
central acidic (CA) domain which is a key component to binding the Arp 2/3 complex (Sitthidet et al. 
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2010). This CA domain is commonly found in WASP binding proteins and is found in other bacterial 
factors such as Listeria ActA, and Rickettsia RickA.  They also differ in the number of WH2 domains 
and proline-rich motifs (Stevens et al. 2005). BimAps contains three WH2 domains whereas BimAth and 
BimAma only contain one WH2 domain (Stevens et al. 2005). The PDAST repeat region is also only 
present in BimAps. BimAma is also much shorter and more proline rich. Interestingly a bimA mutant of 
B. pseudomallei actin-based motility can be restored by BimAth and BimAma (Stevens et al. 2005). It has 
been shown that BimA is highly conserved amongst natural populations of Burkholderia species 
(Sitthidet et al. 2008).  
 
Figure 6: The functional domains of BimA in the closely related Burkholderia species 
 
Figure shows functional 
domains of BimA in B. 
thailandensis, B. mallei and B. 
pseudomallei. Unique to 
BimAps is the additional WH2 
domains and PDAST repeat 
region. Unique to BimAth is the 




Burkholderia intracellular motility factor A 
Analysis of the B. pseudomallei BimA protein has led to a better understanding of its function. Figure 
7 shows a schematic of the predicted functional domains in BimA. The first 1-53 amino acids are a 
predicted signal sequence. The C terminus acts as a membrane anchor similar to other Type V secreted 
proteins. There is a proline rich motif which is not needed for actin binding and polymerisation 
(Sitthidet et al. 2011). The protein contains three actin-binding WASP homology (WH2) domains and 
removal of either of these inhibited actin-based motility. These domains were shown to be vital to 
actin binding and polymerisation (Sitthidet et al. 2011). There are varying numbers of PDAST repeats, 
ranging between 2-7 motifs, which have been shown to affect actin polymerisation (Sitthidet et al. 
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2011). As the number of PDAST repeats increased so did the rate of actin polymerisation, however the 
repeats did not influence actin binding.  
 
Figure 7 showing predicted functional domains of BimA protein: 
Figure shows the amino acid sequence of BimA with the functional domains highlighted. X – Putative 












A similar observation has been seen in Enterohaemorrhagic Escherichia coli (EHEC) a common food-
borne pathogen. It colonises the gut epithelium at the border of the microvilli forming actin pedestals 
beneath adherent bacteria. EHEC translocates the receptor protein Tir, allowing it to link the 
bacterium to the actin cytoskeleton of the host cell. A Type 3 Secreted effector protein Tccp (Tir 
cytoskeleton coupling protein) is required for Tir to mediate actin accumulation. Tccp binds to N-WASP 
which stimulates Arp 2/3 resulting in polymerisation of actin. The number of proline rich motifs in 
Tccp was shown to influence actin pedestal formation (Garmendia et al. 2006). Proline rich motifs are 
found in most pathogens that utilise NPFs in their weaponry to influence recruitment of actin 
monomers. The number of proline motifs in Listeria ActA has also been shown to influence the rate of 






Aim and Objectives 
To investigate the effect of phosphorylation of BimA on actin-based motility of B. pseudomallei 
This project aims to reveal new insights into the mechanism behind actin-based motility of B. 
pseudomallei. Actin polymerisation has been shown to be vitally important to intracellular survival of 
B. pseudomallei and the identification of phosphorylation sites in the BimA protein could lead to the 
development of novel anti-infectives. The PDAST repeats are a potential target for phosphorylation 
and their varying number suggests they could play an important role in the function of the protein. 
Specific phosphorylation sites in the BimA protein and predicted protein targets of CK2 have been 
identified raising the possibility of exploiting this information to improve therapy strategies. Vaccines 
could potentially be developed to provide protection against this pathogen that causes severe disease. 
Listeria ActA has already shown good promise as a vaccine candidate (Darji et al.  2003) and the aim 
is for BimA to be a possible candidate from the results of this study.  
 
Objectives: 
• Perform a bioinformatics analysis to identify potential phosphorylation sites of BimA and 
the identity of cellular kinases involved in this modification.  
• Identify sites of phosphorylation by mass spectrometry of BimA immuno-precipitated 
from cells.  
• Generation of a B. thailandensis bimA deletion mutant which would allow live cell imaging 
at lower containment level.  
• Generate Phospho-mimicking and phospho-null BimA mutant proteins by substituting 
Serines residues in the PDAST repeat region for alanine (for a null mutant) and aspartic 
acid (for a charged constitutively-phosphorylated mutant). These will be used to show the 
effect of phosphorylation on actin-based motility by expressing these mutant proteins in 







Chapter 2: Materials and Methods 
Bioinformatics analysis of B. pseudomallei BimA  
Three online phosphorylation prediction databases were used to identify predicted 
phosphorylation sites in the B. pseudomallei BimA amino acid sequence (strain 10276, accession 
number EU439427): 
Netphos (http://www.cbs.dtu.dk/services/NetPhos/) 
ELM (http://elm.eu.org/)  
GPS 3.0 (http://gps.biocuckoo.org/) 
GPS 3.0 was then used to search for host cell kinases predicted to phosphorylate each residue. 
The score value is calculated by the GPS algorithm to evaluate the potential of phosphorylation at 
each residue. The higher the value, the higher the likelihood the residue is phosphorylated. The 
highest scoring kinases predicted for each phosphorylation site were recorded.  
 
Transfection of HeLa cells with CD32-BimA 
A HeLa cell suspension was diluted in Dulbecco’s Modified Eagle Medium (DMEM) supplemented 
with 10 % (v/v) heat inactivated foetal calf serum (FCS) to achieve a concentration of 5.5 × 105 
cells / ml. 1.1 × 106 cells were seeded to each test well on a 6-well plate. The 6-well plates were 
incubated at 37 ˚C with 5% CO2 overnight.  
pCD32-BimA was purified using the Qiagen miniprep spin kit from an overnight culture of E. coli 
containing pCD32-BimA (previously generated by Stevens laboratory, Stevens et al. 2005). 2µg 
pCD32-BimA was added to Optimem (Gibco) before combining with Lipofectamine (Invitrogen) 
for 20 mins at room temperature. The combined 2µg pCD32-BimA and Lipofectamine was then 
added to the test wells and incubated for the appropriate time at 37 ˚C with 5% CO2. Optimem 
was added to control wells.  
 
Costaining of cells 
Following 24 or 48 hours incubation of cells transfected with pCD32-BimA, media was removed 
and cells were fixed overnight with 4% Paraformaldehyde/Phosphate Buffered Saline (PBS). Cells 
were washed twice with PBS and then permeabilised with 0.5% Triton X-100 in PBS for 15 minutes 
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at room temperature. Cells were washed twice with PBS. 0.5% Bovine serum albumin (BSA)/PBS 
was then added for 30 minutes at room temperature. Coverslips were transferred onto parafilm 
on wet tissue paper. 1 µg/ml anti-CD32 antibody (Genetex) in BSA/PBS was added to the coverslips 
at 37 °C for 1 hour. Coverslips were washed thoroughly in PBS. 1 µg/ml anti-mouse antibody 568 
in BSA/PBS was added to the coverslips and incubated at 37 °C for 1 hour.  Coverslips were washed 
as before. 5 U/ml Phalloidin 488 was added for 20 minutes at room temperature. Coverslips were 
washed as before.  Coverslips were then stained with 9.53 µM DAPI and then washed in water 
before being mounted on glass slides with 15 µl of Prolong Gold (Molecular Probes).  
In some experiments, intracellular bacteria were detected by incubating with either primary 
antibody used was anti-LPS Rab 204 at 1 in 200 dilution. 2nd antibody used was 1 µg/ml anti-rab 
568 (Invitrogen) or primary antibody used was 1 µg/ml mouse anti-Pseudomonas mallei LPS. 
Secondary antibody used was 1 µg/ml anti-mouse 568 (Cell signalling).  
 
Confocal microscopy 
Coverslips were imaged using Zeiss LSM 710 confocal microscope and a 40X lens objective. 
Fluorophores were excited with lasers at 365 nm, 488 nm and 568 nm.  Emissions were detected 
using mirror/ band-pass filters at 420-470 nm, 500-550 nm and 570-640 nm. Images were then 
processed using Zen and Image J software. 
 
Immunoprecipitation 
Media from a pCD32-BimA transfected 6-well plate was removed and cells were washed twice 
with PBS. Cells were lysed with Non-denaturing lysis buffer (NaCl 150 mM, Tris (Ultrol) 10 mM, 
NP40 2 %, EDTA 5 mM) containing inhibitors: 1 mM PMSF, 2 mM Na orthovanovate, 10 µg/ml 
Leupeptin, 10 µg/ml Aprotonin, 1 µg/ml Pepstatin, 4 mM NaF, 2 mM Napyrophosphate and 
centrifuged at 16000 X g  for 5 minutes. The supernatant was transferred into an eppendorf and 
incubated with 2 µg anti-CD32 antibody (Genetex) overnight at 4°C on a rocking platform. 80 µl of 
protein A-agarose beads (Sigma) (pre-washed in PBS) was added and incubated at room 
temperature for 1 hour. The immunoprecipitated protein was washed three times with ice-cold 





SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein separations by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) were as described by 
Laemmli (1970). Samples were prepared by adding an equal volume of 2X Reducing Sample 
Treatment Buffer (RSTB) with 1/50 volumes of β-Mercaptoethanol. Samples were incubated at 
95°C for 10 minutes immediately prior to electrophoresis. Gels (Bio-Rad Any Kd) were run using 
Bio-Rad Protein 2 apparatus and gels were submerged in running buffer (25 mM Tris-HCL, 192 mM 
glycine, 0.1 % SDS) for electrophoresis.  
Gels washed twice for 5 minutes with water were then stained with Simplyblue Safestain for 1 
hour at room temperature. Gels were then de-stained in water. Alternatively gels were silver-
stained. Gels were fixed twice for 15 minutes in 30 % (v/v) ethanol and 10 % (v/v) acetic acid 
solution followed by two washes for 5 minutes in 10 % (v/v) ethanol, then two washes for 5 
minutes in water. Gel was sensitized with Sensitizer solution (0.2 % Sensitizer in water, Pierce 
Technologies) for 1 minute, then washed twice for 1 minute with water. Gel was then stained with 
Stain solution (2 % Enhancer in Silver stain, Pierce Technologies) for 30 minutes before two washes 
for 1 minute with water. Gel was then developed with Developer solution (2 % Enhancer in 
Developer, Pierce Technologies) until bands appeared before a final wash with 5 % (v/v) acetic 
acid.  
 
Western blotting  
Transfer of protein to nitrocellulose membranes (GE Healthcare Life Science) was performed using 
Bio-Rad Trans-Blot Turbo transfer apparatus at 2.5 A and 25 V for 3 minutes, submersed in transfer 
buffer (25 mM Tris-HCL, 192 mM glycine, 20 % methanol). Following transfer, membranes were 
first blocked using PBS containing 5 % (w/v) non-fat milk protein for 1 hour at room temperature. 
Following two 5 minutes washes in PBS containing 0.1 % (v/v) Tween-20 (PBS-T), membranes were 
then incubated in 1˚ antibody diluted in PBS-T. Primary antibodies used were mouse anti-FB5, 
anti-AF8 and anti-FG11 at 0.5 µg/ml and 1 µg/ml goat anti-actin (Genetex). Following two 5 
minutes washes in PBS-T membranes were incubated for 1 hour at room temperature with 2˚ 
antibody diluted in PBS-T. Secondary antibodies used were anti-mouse 680 (Cell signalling) and anti-
goat 800 (IR Dye) at 1 µg/ml. Membranes were then washed five times for 5 minutes in PBS-T before 
a final wash of PBS for 5 minutes. Antigens were detected using the Li-Cor (Biosciences) image 




In-Gel Trypsin Digest of Proteins Separated by SDS-PAGE 
Gel bands were excised with a clean scalpel and diced into 1 mm cubes before being transferred 
to a 1.5 ml Protein Low binding eppendorf.  Bands were washed with 25 mM Ammonium 
Bicarbonate for 30 minutes at room temperature. Bands were then washed with 50 % (v/v) 25 
mM Ammonium bicarbonate in Acetonitrile for 30 minutes and again with Acetonitrile for 10 
minutes. Samples were dried in a SpeedVac for 10 minutes before incubation with the reducing 
reagent 10 mM DTT (25 mM Ammonium Bicarbonate solution) for 1 hour at 56 ̊ C. Gel pieces were 
washed with 5 mM Ammonium Bicarbonate solution and then incubated with the alkylating 
reagent 55 mM Iodoacetamide for 30 minutes in dark at room temperature. Following two washes 
with 50 % (v/v) 25 mM Ammonium bicarbonate in Acetonitrile for 10 minutes and one wash with 
Acetonitrile for 10 minutes the gel pieces were dried in SpeedVac for 10 minutes. Trypsin was 
added and the gel was digested overnight. Extraction buffer 50 % (v/v) Acetonitrile and 0.1 % 
Formic acid was added and incubated for 30 minutes before drying and analysis by Proton 
Magnetic Resonance (PMR) Spectrometer.  
 
Mass Spectrometry analysis 
Analysis was carried out on the in-gel Trypsin digest of CD32-BimA by the proteomics team at the 
Roslin institute. Another sample of immunoprecipitated CD32-BimA was generated and eluted in 
an elution buffer containing 100 mM Tris-HCl (pH7.6) and 4% (w/v) SDS before mass spectrometry 
analysis by Dundee Cell Products. Expected peptides were generated by trypsin digest of CD32-
BimA in silico generated using ExPASY peptide cutter (Gasteiger et al. 2005). 
 
Extraction of B. thailandensis genomic DNA 
A B. thailandensis (E30 strain) 10 ml stationary phase culture was collected by centrifugation at 
16000 X g for 5 minutes. Cells were resuspended in 567 µl TE buffer (10 mM Tris-HCl (pH8.0) and 
1 mM EDTA (pH8.0). 30 l of 10 % SDS and 3 l of 20 mg/ml Proteinase K was added and incubated 
at 37 C for 2 hours. 100 l of 5 M NaCl was added before 80 l of CTAB/NaCl solution (8.2 g NaCl, 
20 g hexadecyltri-methyl ammonium bromide (CTAB) in 200 ml water; filter-sterilised). 750 l of 
phenol:chloroform:isoamyl alcohol was added to the CTAB/NaCl solution, mixed thoroughly and 
centrifuged at 16000 X g for 40 minutes. The aqueous supernatant was removed to a fresh 
microfuge tube and the wash step was repeated and centrifuged for 30 minutes. A third extraction 
was repeated and centrifuged for 15 minutes. The aqueous supernatant was removed and 450 l 
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of room temperature isopropanol was added before being centrifuged at 16000 X g for 10 
minutes. Supernatant was removed and 400 l 70 % (v/v) ethanol was added to rinse the pellet 
before being centrifuged at 16000 X g for 5 minutes. Supernatant was removed and pellet was 
allowed to air dry. This was resuspended in 50 l water before adding RNase to a final 
concentration of 10 g/ml and incubated for 20 minutes at room temperature. The DNA was then 
quantified using the Nanodrop spectrometer (ND-1000 Labtech International). 
 
Polymerase chain reaction 
Polymerase chain reactions (PCR) were performed in 20 µl volumes, using 1 µg template DNA, 0.5 
µM oligonucleotide primers and 500 µM deoxynucleotides. To each reaction GC Rich Phusion 
buffer (Invitrogen) was added to final concentration of 1.5 mM MgCl2 and 1 % DMSO. 0.4 units of 
Phusion polymerase (Invitrogen) was then added and 50 cycles of amplification performed. 
Templates were denatured at 98 ˚C for 3 minutes, primers annealed at 65 ˚C and extension 
performed at 72 ˚C.  
 
Agarose gel electrophoresis 
Agarose was used at 1 % (w/v) for resolution of DNA fragments, in TAE buffer pH 7.7 (40 mM Tris-
acetate, 1 mM EDTA) containing 1 % (v/v) Syber safe DNA stain (Invitrogen). Prior to loading, 
samples were mixed with 1/6 volumes of 6 X loading dye (Invitrogen) Electrophoresis was 
performed at a constant voltage of 90 V in TAE buffer. DNA was visualised under ultraviolet light 
using a Geldoc (Alpha Innotech).  
 
PCR product gel purification 
DNA bands were cut out of the gel and purified following the protocol in the Geneclean kit. The 







PCR-Ligation-PCR (PLP) mutagenesis 
To construct fusions between the upstream and downstream flanking sequences of B. 
thailandensis bimA, the method of PLP mutagenesis described by Ali and Steinkasserer (1995) was 
used. Firstly, the two sequences to be fused together were separately amplified by PCR using 
Phusion polymerase. Approximately the same molar quantities were then phosphorylated at 37 
˚C for 2 hours. Phosphorylation reactions were performed in a 30 µl reaction volume containing 1 
mM ATP, 50 U T4 Polynucleotide kinase (Promega) and T4 Polynucleotide kinase buffer (Promega) 
consisting of 50 mM Tris-HCl, 10 mM MgCl2, 5 mM DTT, 100 µM spermidine. Ligation was 
performed by combining 25 µl of the phosphorylation mix with 3U of T4 ligase (Promega) and T4 
ligase buffer (Promega) at 4˚C overnight.  Finally 1 µl of ligation reaction was used in a PCR reaction 
using external primers to amplify the fusion product.   
 
Subcloning into pGEMT 
Firstly, the sequence to be fused into pGEMT (Promega) was amplified by PCR using Phusion 
polymerase. The product was A-tailed at 72 ˚C for 30 minutes. A-tailing reactions were performed 
in a 10 µl reaction volume containing 1 mM MgCl2, 2.5 U Taq DNA polymerase (Invitrogen), 1 mM 
dATP and PCR buffer (Invitrogen). Ligation was performed by combining the 10 µl mix with 3 U T4 
ligase (Promega), 50 ng pGEMT EASY (Promega) and T4 ligase buffer (Promega) at 4 ˚C overnight. 
 
Transformation of E. coli  
50 µl XL1-Blue Competent cells (Agilent Technologies) or 50 µl PIR1 One Shot cells and typically 
0.1 to 1 µg plasmid DNA were mixed and incubated on ice for 30 minutes. The cells were then 
incubated at 42 ̊ C for 30 seconds, placed on ice for 2 minutes and then 0.5 ml Super Optimal broth 
with Catabolite repression (SOC) medium was added. Transformed cells were incubated at 37 ˚C 
for 1 hour and dilutions then plated onto selective medium.  
 
Plasmid purification 
Colonies from transformation were grown to mid-logarithmic phase (A600   ̴̴ 0.5) in Luria Broth (LB). 
Cells were centrifuged at 3000 X g for 10 minutes and plasmid DNA was purified following the 
protocol in the QIAgen miniprep kit. 
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Restriction digest of plasmids 
Purified plasmids were cut using restriction enzymes at 37 ˚C for 4 hours. Restriction digests were 
performed in a 10 µl reaction volume containing either 12 U EcoR1 (Promega), 20 U Xho1 
(Promega) or 15 U Xba1 (Invitrogen) and CutsmartBuffer (Biolabs). Products were analysed by 
agarose gel electrophoresis.  
 
Cloning into pDM4 
Firstly, the insert and pDM4 were digested with Xho1 and Xba1 to generate sticky ends. 
Approximately the same molar quantities were then ligated at 4 ˚C overnight. Ligation was 
performed by combining the 20 µl mix with 9 U T4 ligase (Promega), 1 mM ATP and T4 ligase buffer 
(Promega). 
 
Colony PCR  
For rapid screening of bacteria for specific DNA sequences, colony PCR was performed (Clackson 
et al. 1991). A reaction mix consisting of primers, deoxynucleotides, Phusion polymerase 
(Invitrogen) in a GC rich Phusion buffer (Invitrogen) was prepared and 20 µl dispensed into 0.2 ml 
PCR tubes. To each tube, a small amount of bacteria was then added using a sterile pipette. 
Reactions were heated to 98 ˚C for 3 minutes then 50 cycles of PCR performed. New primers were 
designed so that they would amplify the flanking regions of bimA and be specific for both B. 
pseudomallei and B. thailandensis. The new primers required a lower annealing temperature at 
46 °C.  
 
Growth of B. thailandensis strains 
Glycerol stocks of B. thailandensis strains E30, BpG488, Bp9, Bp69, BpG1190 and Bp4 were spread 
onto LB plates with or without selection (50 µg/ml Chloramphenicol or 50 µg/ml Kanamycin) and 






Conjugation of S17- λ pir pDM4-bimA with B. thailandensis 
Single colonies of B. thailandensis E30 and S17- λ pir pDM4-bimA were grown to stationary phase 
in LB and selective LB media and then diluted in LB broth to A600   ̴̴ 0.5. S17- λ pir pDM4-bimA has 
been previously generated by Charles Vander Broek. Conjugation reactions containing 10 mM 
MgSO4 and 0.5 ml bacterial culture were performed through a filter membrane into sterile 
universals. The filter was placed on a LA plate and incubated at 37 °C overnight. The filter was 
vortexed in LB broth before serial dilutions were spread on selective plates and incubated at 37 
°C for 2 days. Colony PCR was performed on single colonies and then agarose gel electrophoresis.  
 
Sucrose selection 
Positive single colonies showing the correct size band from PCR screen were grown to stationary 
phase in LB broth. Serial dilutions were then spread on 15 % (w/v) sucrose plates lacking NaCl and 
incubated at 30 °C for 2 days. Colony PCR was performed on single colonies and analysed by 
agarose gel electrophoresis. 
Sucrose plates 
4 g Tryptone (Oxoid), 2 g Yeast Extract (Oxoid) and 6 g Bacto Agar (Difco), in 200 ml distilled water 
(pH 7.25) with 15% (w/v) Sucrose (Sigma).  
 
Infection of HeLa cells with possible B. thailandensis bimA mutants 
Sterile coverslips were placed in a 24-well plate and 2 X 105 cells/ml HeLa cell suspension was 
seeded overnight at 37 ˚C with 5 % CO2. Positive single colonies showing the correct size band 
from PCR screen were grown to stationary phase in LB broth. Bacterial culture was diluted 1/100 
in DMEM and added to the wells. The plates were centrifuged for 5 minutes at 300 x g and then 
incubated at 37 ˚C for 30 minutes. Media was removed and then an overlay of 1 ml DMEM with 
kanamycin 250 µg/ ml was added. The plate was incubated overnight at 37 ˚C with 5 % CO2 and 
then fixed with 4 % paraformaldehyde. Coverslips were then stained to detect bacteria and actin 






Generation of a null and constitutively phosphorylated mutant pME-BimA  
Glycerol stocks of E. coli containing pME and pME-BimA (previously generated from Stevens 
laboratory) were streaked onto LB agar containing 15 µg/ml tetracycline. Single colonies were 
then grown to stationary phase in selective LB broth. Cells were pelleted at 3000 X g at 4 ˚C for 10 
minutes before the plasmid was purified using the Qiagen Maxiprep spin kit. Purified pME-BimA 
was then mutated by Dundee Cell Proteomics. Phosphorylation mutant plasmids pME-BimA S/A 
and pME-BimA S/D were generated by mutating the Serines in the PDAST repeat region of BimA 
to Alanines for a phospho-null and Aspartic acid for a phospho-mimic.  
 
Transformation of pME-BimA into B. pseudomallei 
Transformation of BimA mutant plasmids B. pseudomallei were performed by Jo Stevens. B. 
pseudomallei harbouring pME-BimA S/D and pME-BimA S/A was grown to stationary phase in LB 
broth containing 0.25 mM IPTG and 15 µg/ml tetracycline and expression of BimA was checked by 
western blot from bacterial lysates.  
 
Infection of HeLa cells with B. pseudomallei ΔbimA mutant strains 
Single colonies of B. pseudomallei 10276 and ΔbimA mutants carrying pME, pME-bimA, pME-bimA 
S/A and pME-bimA S/D were grown to stationary phase in LB broth containing 0.25 mM IPTG and 
15 µg/ml tetracycline. Strains were then sub-cultured into LB broth containing 0.25 mM IPTG and 
15 µg/ml tetracycline and incubated with shaking at 200 rpm at 37 °C for 4 hours. 
Bacterial cultures were diluted to A600   ̴̴ 0.5 followed by diluting 1/100 in DMEM containing 0.25 
mM IPTG to produce the infection inoculum. Media was removed from wells that had been seeded 
with HeLa cells in suspension at 2 x 105 cells/ml on coverslips. 1 ml of the inoculum was added to 
each well. The infection was synchronised by centrifugation at 300 x g for 5 minutes. The plate 
was then incubated at 37 °C for 30 minutes. Infection media was removed and then replaced with 
DMEM containing 10 % FCS, 0.25 mM IPTG and 250 µg/ml Kanamycin. Plates were incubated at 
37 ˚C for 20 hours. 
Media was removed from all wells and replaced with 1 ml 4 % PFA in PBS to fix the cells. Coverslips 





ImageJ analysis  
Images taken from confocal microscopy were further analysed in Image J to calculate the actin tail 
length. The protocol from the Image J manual was followed to calculate the Feret’s diameter. This 
value is the longest distance between any two points along the selection boundary and is also 
known as the maximum calliper.  
 
Intracellular survival of B. pseudomallei ΔbimA mutant strains 
An infection of HeLa cells by B. pseudomallei 10276 and ΔbimA mutants was performed. Bacterial 
cultures were diluted to A600   ̴̴ 0.5 followed by diluting 1/100 in DMEM.  At 20 hours post-infection, 
media was removed and cells were washed twice with PBS. Cells were then lysed with 200 µl of 
0.1 % (v/v) triton X in PBS followed by serial dilution in LB broth and plating onto LA plates. Plates 
were incubated for 2 days at 37 ˚C. The infection inoculum was serially diluted in LB broth and 
followed by plating onto LA plates incubated at 37 °C for 2 days. 
 
Purification and concentration of GST-BimA 
Single colonies of E. coli containing pGex-BimA were grown to stationary phase in LB broth 
containing 100 µg/ml ampicillin. This was sub-cultured into LB broth containing 100 µg/ml 
ampicillin and 10 µg/ml chloramphenicol at 37 °C for 3 hours. IPTG was added to achieve a final 
concentration of 0.25 mM and then incubated for a further 3 hours. Cells were centrifuged at 3000 
X g at 4 ˚C for 10 minutes before being lysed with 5 % (v/v) Bugbuster (Novagen) and then 
incubated at room temperature for 20 minutes. The insoluble debris from the Bugbuster 
(Novagen) extractions was centrifuged at 3000 X g at 4 ˚C for 10 minutes. 200 µl of GSH agarose 
(pre-washed in 500 µl PBS) was added to the supernatant and incubated on a rocking platform at 
room temperature for 30 minutes. The GSH was then washed 4 times with PBS. 150 µl of elution 
buffer (10 mM reduced glutathione in 50 mM Tris, pH8.0) was added to GSH and incubated at 
room temperature for 10 minutes on a rocking platform. The sample was then centrifuged 16000 
X g to pellet the beads and the eluate was transferred to a chilled eppendorf. This step was 
repeated 3 times to achieve a combined eluate of ~600 µl. Beads were washed by vortexing in PBS 
and centrifuged at 16000 X g before transferring the wash to the eppendorf containing the eluted 
protein. The eluate was then passed through a Novagen 2ml spin filter column and centrifuged at 
16000 X g to remove any remaining beads and stored at 4 ˚C. The protein sample was diluted to 
1.5 ml with 50mM Tris, pH7.5 and loaded into a U-tube concentrator 2H-2 centrifuged 16000 X g 
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for 30 minutes. The sample was diluted to 1.5 ml and centrifuged again. This step was repeated 5 
times leaving ~200 µl protein solution.  
 
In vitro Phosphorylation of GST-BimA by host cell kinases 
Phosphorylation reactions of GST-BimA were performed in a 40 µl reaction volume containing 200 
µM ATP, 1000U Casein Kinase 2 (NEB) or Glycogen synthase kinase 3 (NEB), 2 mM Na 
orthovanovate, 4 mM Na F, 2 mM Na pyrophosphate and NEB buffer (NEB) at 30 °C for 2 hours. 
Samples were loaded into a Phostag gel and run by SDS-PAGE electrophoresis. The gel was then 
SimplyBlue stained and the correct band was cut out and sent for mass spectrometry analysis at 
Dundee Cell Products. Trypsin gel digest and mass spectrometry analysis was then carried out by 
Dundee cell Products on in vitro kinase reaction of GST-BimA.  
 Recipes for 100 µM Phostag Gel:  









30% acrylamide 1.333 µl 
1M Tris pH 6.8( to 375µM) 1.5ml 
10% SDS 40 µl 
Water 967 µl  
TEMED 12 µl 
10% Ammonium persulfate 60 µl 
5mM Phostag 80 µl 
10mM MnCl2 80 µl 
30% acrylamide 300µl 
1M Tris pH 6.8( to 375µM) 750µl 
10% SDS 20µl 
Water 930 µl 
TEMED 10 µl 
10% Ammonium persulfate 50 µl 
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Table of primers used for PCR 
Primers Sequence Restriction 
Enzyme site 
Experiment 
P1 ATATATCTCGAGACGTCGCATACAGCCT Xho1 PLP 
P2 CATACGGCGAGGATGGATTGAA  PLP 
P3 TGAGCGCGCCGCAAGCGCTCACCGCACACA  PLP 
P4 ATATATGGTTACCCGAAGAGCGAAGAGCGCGCCGCGC BSte2 PLP 
P2 ATATATTCTAGACATACGGCGAGGATGGATTGAA Xba1 Subcloning pGEMT 
P1 ATTCACGCATCCGGTCA  Colony PCR 


















Chapter 3: Identification of sites of BimA phosphorylation 
 
Bioinformatics analysis of phosphorylation sites of BimA 
There are around 500 kinases in the human genome many of which regulate key proteins by 
phosphorylation. A bioinformatics analysis of a protein of interest allows for phosphorylation sites and 
associated kinases to be predicted and potentially investigated further. It is possible that a predicted 
phosphorylated site in BimA could enhance its function and affect the actin-based motility of B. 
pseudomallei. 
Online prediction tools (NetPhos, Elm and GPS 3.0) have been used to predict phosphorylation sites 
of BimA (Blom et al. 1999) (Puntervoll et al. 2003) (Xue et al. 2011). The amino acid sequence was 
searched through these databases and the combined data showed that in total 37 sites (18 Serines, 
17 Threonines and 2 Tyrosines) in the BimA sequence are predicted to be phosphorylated as shown in 
Figure 8.  Figure 9 displays the GPS 3.0 output of these phosphorylation sites and identifies candidate 
host cell kinases that are predicted to phosphorylate BimA at these sites.  
 
Figure 8: Predicted phosphorylation sites of BimA  
Figure shows the combined predicted phosphorylation sites of BimA sequence from online prediction tools. 
Predicted phosphorylated amino acids are shown by either S, T or Y for Serine, Threonine or Tyrosine. The 
functional domains are also highlighted: X – Signal sequence 1-53, X – Proline rich motif 90-97, X – WH2 motifs 





Figure 9: Host cell kinases predicted to phosphorylate BimA 
The BimA amino acid sequence (1-529) was searched through GPS 3.0 on a high threshold and the highest scoring 
kinases are shown in the table. For each site the functional domain, position in sequence and specific predicted 
kinases are given. In red is the predicted phosphorylated Serine/Threonine/Tyrosine.  
 
 
Predicted phosphorylation sites were identified in all functional domains of BimA apart from the 
proline rich motif. This region has previously been shown to be dispensable for actin binding (Sitthidet 
et al. 2011). A higher number of sites were predicted to be phosphorylated in the PDAST repeat region 
compared to other regions of BimA. This suggests the PDAST repeat region is more likely to be 
phosphorylated. Recent studies have showed an additive effect on actin polymerisation as the number 
of PDAST repeats increases (Sitthidet et al. 2011). This could be because of phosphorylation and so 
the Serine and Threonines in this region are good targets for BimA mutagenesis.  
Functional Domain Position Sequence Enzyme
19 HAKASSSHA DUN1, IKKb, BARK1
20 AKASSSHAP PIM2, SIK2, CK1e, TRPM7
30 APKPSSIAT NEK6, RPS6KA4
35  SIATTLCRA  PLK2, CaMKK1, CaMKK2
104  IGGATPSPP  ERK5, ERK2, GSK3
111 PPPLTPVNG MAPK14, JNK2, MAPK11, NLK, ERK2
121  PGASTPTKT  CDK2, MAPK12, JNK1, ERK2
135 LNRLSAELQ ROCK1,  PAK4, PKC-gamma, PKA C-alpha
145 NPRVTEDVV MAP2K2
171 NGDFSGRSA IKKb
188 AALRSLKKN PKA C-alpha
225 EALESNRPP MAPK13
235 PQPRSTPPQ CDK6, DYPR1
236 QPRSTPPQS MAPK14, GSK3, NLK, JNK2, ERK1
241 PPQSTPPKP GSK3, MAPK14, MAPK12, JNK2, ERK2 
246 PPKPTQHPT HIPK2
260 VPDASTPDA BARK1, AMPKA2, CLK1, MNK1, DUN1, CK2a1
261 PDASTPDAS MAPK13,  GSK3, CDK6, ERK1, CK1e
265 TPDASTPDA BARK1, AMPKA2, CLK1, MNK1, DUN1, CK2a1
266 PDASTPDAS MAPK13,  GSK3, CDK6, ERK1, CK1e
270  TPDASTPDA  BARK1, AMPKA2, CLK1, MNK1, DUN1, CK2a1
271 PDASTPDAS MAPK14, GSK3, CDK6, ERK1, CK1e
275 TPDASTPDA BARK1, AMPKA2, CLK1, MNK1, DUN1, CK2a1
276 PDASTPDAS MAPK14, GSK3, CDK6, ERK1, CK1e
280 TPDASTPSR MNK1, AMPKA2, TRPM7, BARK1, DUN1, CK2a1
281  PDASTPSRP  MAPK14, GSK3, ERK2, MAPK13, CK1e
293  PRAGTGAPA  CDK8
391 LGSGSIAER BRSK1, NPR1
398 EREGTVSVG PLK4, DYRK2, MRKCKa, CAMK2














The analysis shows that BimA contains a lot of predicted sites for phosphorylation by cellular kinases, 
particularly serine/ threonine kinases. CK2 is a highly conserved protein kinase able to phosphorylate 
more than 300 substrates. Many of these proteins are involved in signal transduction, gene expression 
and other nuclear functions (Pinna 2002). Studies have shown a role in regulating cytoskeletal proteins 
as phosphorylation of Serine residues in WASP by CK2 increased the affinity for Arp 2/3 complex (Cory 
et al. 2003). 
CK2 is a serine/threonine kinase that is ubiquitously expressed and has been shown to affect Listeria 
actin-based motility by phosphorylating the bacterial factor ActA (Chong et al. 2009). ActA is able to 
mimic host NPFs and recruit the Arp 2/3 complex to the pole of the cell. It displays structural similarity 
with the VCA domain of other NPFs where the Arp 2/3 complex can bind. It is within this region where 
CK2 phosphorylates ActA. Studies have shown that within the C region of the VCA domain is a CK2 
binding motif (Chong et al. 2009). This motif contains two Serines that are phosphorylated by CK2. 
ActA phosphorylation mutants showed the importance of these two Serines as survival in a mouse 
model of a S/A and S/D mutant was affected. A reduced bacterial load was seen for the 
phosphorylation mutants compared to the wildtype. The phospho-mimic mutants were attenuated in 
their ability to spread from cell to cell and the data suggests that phosphorylation of this region needs 
to be tightly regulated for efficient actin-based motility (Chong et al. 2009). Therefore CK2 is vital to 
actin-based motility of Listeria by regulating the binding of the Arp 2/3 complex to ActA.  
CK2 was predicted to phosphorylate Serines in the PDAST region of BimA shown in Figure 9. It is 
possible CK2 could phosphorylate BimA and affect B. pseudomallei actin-based motility in a similar 
way as in Listeria. However for B. pseudomallei actin-based motility has been shown to be 
independent of the Arp 2/3 complex. CK2 could potentially phosphorylate BimA in the PDAST region 
and regulate the binding of another host protein. CK2 has also been shown to be important for actin 
tail formation in another intracellular pathogen, vaccinia virus (Alvarez et al. 2012). A GST-BimA fusion 
protein has also been shown to be phosphorylated by CK2 in an in vitro kinase assay using 
radiolabelled 32P-ATP (unpublished data from Stevens laboratory). CK2 therefore is a good candidate 
because it has been predicted to phosphorylate BimA, regulates cytoskeletal proteins and it has a role 
in actin tail formation for other intracellular pathogens. Inhibitors for CK2 such as 4, 5, 6, 7-
tetrabromo-2-azabenzimidazole (TBB) could be used to investigate the effect of phosphorylation on 
actin-based motility of B. pseudomallei (Sarno et al. 2002).   
Other kinases could also phosphorylate BimA and glycogen synthase kinase-3 (GSK-3) was another 
prominent kinase that came out of the bioinformatics analysis shown in Figures 6 and 7. GSK-3 was 
predicted to phosphorylate Threonines in the PDAST region by the online prediction tools. It was 
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originally identified as a regulator of glycogen metabolism, but now is understood to be involved in 
protein synthesis, cell proliferation, cell differentiation, microtubule dynamics and cell motility 
(reviewed in Frame et al. 2001). GSK-3 displays ubiquitous cytoplasmic expression (reviewed in Frame 
et al. 2001). GSK-3 could function similarly as CK2 does in Listeria actin-based motility to regulate the 
binding of host proteins to BimA through phosphorylation. CK2 and GSK-3 could be investigated 
further to investigate their effect on actin-based motility. It is also possible that any of the predicted 
host cell kinases may regulate the binding of actin to BimA or a host protein that stimulates the 
polymerisation of actin.  
Phosphorylation has been predicted in the WH2 domains. These domains are known to be important 
in actin binding (Sitthidet et al. 2011) and studies have shown they are able to mimic host Ena/Vasp 
proteins to initiate the formation of the actin tail (Benanti et al. 2015). Phosphorylation in these 
domains could play a role in regulating the binding of actin to BimA and tail formation. 
Two Tyrosine residues in the C terminal domain have been predicted to be phosphorylated from this 
analysis. Studies have shown that for actin assembly in EPEC, Tir requires phosphorylation of a tyrosine 
residue in the cytosolic C-terminal domain (Kenny et al. 1997b). This phosphorylation is important for 
formation of actin pedestals in EPEC and could be similar in B. pseudomallei. 
Many kinases have been predicted to phosphorylate BimA and it is possible that multiple kinases 
phosphorylate BimA. These kinases may work together in regulating BimA for an effect to be seen in 
actin-based motility. Many sites have been predicted to be phosphorylated by multiple kinases and 
inhibiting one may not have an effect if another kinase compensates and phosphorylates the same 
site. Further studies could be done to inhibit multiple kinases if no effect is seen for just one. It is also 
possible BimA could be phosphorylated and this has no effect on actin-based motility. This has been 
seen in Chlamydia where phosphorylation of Tarp had no effect on its recruitment of actin (Mehlitz et 
al. 2008) (Jewett et al. 2008).  
Ultimately we want to know if BimA is modified by host cellular kinases to affect the actin-based 
motility of B. pseudomallei. Phosphorylation of these sites could be an important modification for 
BimA to enhance the actin-based motility of B. pseudomallei in the host cell which therefore may 
increase its survival in a host. The phosphorylation sites identified from this analysis are only a 
prediction and may not actually occur however by combining multiple online prediction tools this 
improves reliability. The 37 sites that have been predicted should be compared to actual 
phosphorylation sites identified by standard LC/MS-MS techniques before further studies into their 
effect on actin-based motility are performed.  
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Identifying actual BimA phosphorylation sites 
To identify which of the predicted sites are actual phosphorylation sites for host cell kinases, pCD32- 
BimA was transfected into HeLa cells so it can be expressed and then regulated by the cell. Initial 
experiments involved optimising conditions by investigating different concentrations of pCD32-BimA 
and time points of cell lysis.  BimA has previously been cloned into a eukaryotic expression vector 
where the cytoplasmic sequences of CD32 have been replaced with BimA residues (Stevens et al. 
2005). This resulting fusion protein, CD32-BimA, targets the membrane of the eukaryotic cell and 
mimics the localisation of BimA in B. pseudomallei where it is exposed to the cell cytosol (Stevens et 
al. 2005). Following transfection and expression in the cell the BimA protein was then 
immunoprecipitated and samples were generated for LC/MS-MS.  
 
Transfection of HeLa cells with pCD32-BimA  
HeLa cells were transfected with pCD32-BimA at two concentrations 2 µg and 4 µg to find the optimum 
concentration for expression. Samples were lysed at 48 hours and analysis by western blot showed 
HeLa cells expressing the protein, seen in Figure 10. A positive control of purified GST-BimA was used 
for the BimA antibodies which has a molecular weight of 68 kDa. For both concentrations CD32-BimA 
could be detected at the correct size band of 60 kDa. As both showed good expression, 2 µg was 
chosen as the optimal concentration for transfection and used for the immunoprecipitation 
experiments. Three negative controls were used: a non-transfected cell, cells transfected with only 
Lipofectamine, cells transfected with pCD32. Actin was present in all lysates at the correct size band 












Figure 10: Western blot of lysates from transfected HeLa cells at 48 hours 
Western blot showing expression of CD32-BimA in HeLa cells lysed at 48 hours after transfection with 2µg and 
4 µg of pCD32-BimA using Lipofectamine. Negative controls of transfected, Lipofectamine-treated and cells 
transfected with pCD32 were used. Positive control of GST-BimA was used for the BimA antibodies. Proteins 
detected by incubation with anti-BimA and anti-actin followed by anti-mouse 680 and anti-goat 800 and imaged 




Having optimised the amount of DNA for transfection the next experiment was to optimise the time 
of lysis to obtain maximal CD32-BimA yield. HeLa cells were seeded onto coverslips and transfected 
with 2 µg pCD32-BimA before being fixed at 24 hours and 48 hours after transfection. Coverslips were 
then stained for CD32 actin and nuclei before being imaged on the confocal microscope. Example 
images can be seen in Figure 11. Transfected HeLa cells showed good expression at both timepoints 
however at 24 hours more CD32-BimA positive cells could be seen. This timepoint was chosen for the 
immunoprecipitation step because it showed more transfected cells and therefore was expected to 
yield more BimA protein. 
Transfected cells appeared to show different morphology compared to untransfected cells shown in 
Figure 11. These cells appeared to have a disrupted and irregular shape which is likely to be because 
of the BimA protein recruiting actin and altering the structure of the cell. This cytoskeletal remodelling 
can be seen in Figure 11 by the presence of more stress fibres and membrane ruffles. Lamellipodia 
can also be seen as an actin projection on the leading edge of the cell. The transfection of DNA into 
the cell can also stress the cells and may have an effect on expression or the cell morphology. The cells 
may not be able to cope with too high a concentration of BimA and may be a reason why fewer cells 
were seen at a later timepoint of 48 hours. It is possible that at the later timepoint of 48 hours the 
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BimA protein has recruited more actin and disrupted the cell shape so much that the cells had 
detached. This could be why there are fewer cells at 48 hours after transfection or could be because 



























Figure 11: HeLa cells after transfection with pCD32-BimA 
Microscopy images of HeLa cells transfected with 2 µg pCD32-BimA. Cells were fixed in paraformaldehyde and 
then permeabilised with Triton X 100 before staining with anti-CD32 followed by anti-mouse 568, Phalloidin and 
DAPI. Blue channel – Nuclei, Red channel – CD32, Green channel – actin.  A) Transfected HeLa cells at 24 hours 
and B) Transfected HeLa cells at 48 hours. Scale bar = 10 µm 
A) HeLa cells at 24 hours after transfection with pCD32-BimA 
Blue Channel - Nuclei     Red Channel – CD32-BimA 
 





B): HeLa cells 48 hours after transfection with pCD32-BimA 
Blue Channel - Nuclei         Red Channel – CD32-BimA 
 








Immunoprecipitation of CD32-BimA from transfected HeLa cell lysates   
The optimal expression conditions for transfection, 2 µg DNA and lysis of cells at 24 hours, were used 
and then CD32-BimA was immunoprecipitated. A lysis buffer containing inhibitor phosphatases was 
used to ensure that any phosphorylation of CD32-BimA was retained. Anti-CD32 was used to pull down 
CD32-BimA before adding agarose beads coated with protein A/G to bind to the antibody. This was 
then washed to remove any unspecific binding.   
Initially the BimA protein could not be seen on a Simplyblue or silver stain gel or detected by western 
blot using anti-BimA (data not shown) so a series of experiments were performed to optimise the 
immunoprecipitation (IP). A western blot was carried out on samples from different stages of the 
protocol to find out where the protein was being lost. Lysates were centrifuged before IP to remove 
cell debris so samples were taken for the pellet (insoluble debris), supernatant (lysate that was 
Immunoprecipitated) and then after IP when protein is bound to the beads. A western blot was able 
to detect BimA in both the pellet and supernatant before IP but not after IP shown in Figure 12. There 
was only a faint band seen for BimA in the pellet compared to the supernatant which meant not much 
protein was being lost in that step. This meant therefore that the IP needed to be optimised. Actin 
was also detected and used as a loading control.  
 
Figure 12: Western blot of optimisation of IP 
Western blot showing levels of CD32-BimA in the different stages of IP; Pellet, Cell lysate Before IP and Cell lysate 
After IP. Negative controls of transfected, Lipofectamine-treated and cells transfected with pCD32 were used. 
Proteins detected by incubation with anti-BimA and anti-actin followed by anti-mouse 680 and anti-goat 800 




Safeblue stained gels were used to investigate whether the wash buffer had an effect on antibody 
binding to the beads. Results showed that a diluted wash buffer with a pH 8 increased the binding of 
antibody to beads (Data not shown). A western blot was carried out on lysates that had been 
immunoprecipitated with the diluted buffer and higher pH and was able to detect a faint band for 
BimA as shown in Figure 13.  
 
Figure 13: Western blot before and after IP with optimised conditions 
Western blot showing expression of CD32-BimA before and after IP with using a diluted buffer containing Tris at 
pH8. Negative controls of transfected, Lipofectamine-treated and cells transfected with pCD32 were used. 
Proteins detected by incubation with anti-BimA followed by anti-mouse 680 and imaged by Li-COR. Arrow points 




This level of protein would not be enough for a mass spectrometry analysis so more cells were 
transfected, 1.7 X 107 cells/ ml compared to 1 X 106 cells/ml. Figure 14 shows a western blot of lysates 
after transfecting a higher number of cells and optimising the IP conditions. A higher level of BimA was 
detected in the IP sample compared to before IP. The samples were from equivalent volumes and this 
indicates that the IP had been successful. A higher level of actin was detected after IP. This supports 
the observations by microscopy and in the literature of BimA interacting specifically with actin 
(Stevens et al. 2005) (Sitthidet et al. 2011). However there is also a lot of actin present in the negative 
controls which is probably due to non-specific binding of actin as it is the most abundant cellular 




Figure 14: Western blot of Immunoprecipitated lysates from transfected HeLa cells  
Western blot showing expression of CD32-BimA before and after Immunoprecipitation of pCD32-BimA 
transfected HeLa cell lysates. Negative controls were used of untransfected HeLa cell lysates. Positive control of 
GST-BimA was used for the BimA antibodies. Proteins detected by incubation with anti-BimA and anti-actin 
followed by anti-mouse 680 and anti-goat 800 and imaged by Li-COR. Arrows point to the correct band for CD32-
BimA and actin. This western blot shows expression of BimA from 1/12 of the immunoprecipitated sample and 
an equal proportion of the Before IP sample. 
 
 
After immunoprecipitation the proteins in the sample were separated by SDS-PAGE and the gel was 
silver stained. Results showed many proteins present on the beads suggesting the IP was non-specific 
as shown in Figure 15. This may be because there is likely to be a higher concentration of host cell 
proteins in the lysates compared to the expressed BimA protein which would block the binding of anti-
CD32 antibody to the protein A-agarose. These host proteins would bind to the protein A–agarose and 
are likely to represent insoluble membranes or vesicles that pellet with the beads. In order to improve 
this and make the binding more specific a different antibody could be used for the 
immunoprecipitation. Antibodies specific for BimA could be used which may decrease the non-specific 
binding of other host cell proteins. Coupling of antibody to beads may also improve the specificity and 
pull down. Further optimisation of the IP wash buffer could remove some of the non-specific proteins.  
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It is also possible that some of the host cell proteins identified in the sample could interact directly 
with BimA and be involved in the mechanism of actin-based motility of B. pseudomallei. After 
optimising the Immunoprecipitation further to decrease the number of non-specific protein bands on 
the gel, additional bands to BimA could be cut out of the gel and analysed by mass spectrometry to 
identify the host cell proteins. Any proteins identified could then be investigated further to analyse 
their role in actin-based motility and interaction with BimA.    
 
Figure 15: Silver stained gel of Immunoprecipitated CD32-BimA 
Figure shows a silver stained gel of Immunoprecipitated CD32-BimA. HeLa cells transfected with CD32 and CD32-
BimA were immunoprecipitated with anti-CD32 before being run by SDS-PAGE and then the gel was silver 
stained. The Agarose beads were also loaded as a negative control.  
 
 
Mass Spectrometry of Immunoprecipitated CD32-BimA  
In a previous experiment, multiple bands were cut out and mass spectrometry performed at Roslin 
was able to identify BimA however there was not enough protein for a phosphorylation analysis shown 
in Figure 16. Only 3 out of 40 peptides for a trypsin digest of the immunoprecipitated CD32-BimA 
(Figure 16) sample were detected by mass spectrometry with a 7.5 % coverage of the protein. 
Therefore because of the difficulty in identifying CD32-BimA and to obtain maximum protein an eluate 
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of the sample from the beads was analysed by mass spectrometry by Dundee Cell Proteomics who 
also have a more sensitive mass spectrometer shown in Figure 17.    
 
Figure 16: Mass Spectrometry of Immunoprecipitated CD32-BimA Gel slice 
Figure shows the expected peptides generated by trypsin digest of CD32-BimA in silico generated using ExPASY 












Figure 17: Mass Spectrometry of Immunoprecipitated CD32-BimA Eluate 
Figure shows the expected peptides generated by trypsin digest of CD32-BimA in silico. In red are the actual 
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The analysis shows that 7 out of 40 possible tryptic peptides of the immunoprecipitated CD32-BimA 
sample were detected by mass spectrometry at Dundee Cell Products representing 17.5% coverage of 
the protein. There is a low coverage of the protein and many peptides are not detected. The 
experiment needs to be repeated to determine if the regions such as the PDAST repeat region that 
are not detected are phosphorylated by host cell kinases.  This is a common issue with characterisation 
projects and complimentary mapping could be done to provide better coverage of the CD32-BimA 
protein. This would involve multiple digestions of the protein with different enzymes e.g. 
trypsin/chymotrypsin/AspN/V8 to generate the correct sized peptides for mass spectrometry analysis. 
To achieve a better coverage of peptides a higher number of cells could be transfected and then 
immunoprecipitated. This would increase the concentration and proportion of CD32-BimA compared 
to other nonspecific proteins in the sample. There are 34 predicted phosphorylation sites on the 
peptides that were not detected by mass spectrometry in this experiment. Previous studies have 
shown that BimA is phosphorylated in infected cells using 32P-ATP pulse chase experiments and 
immunoprecipitation methods (unpublished data from the Stevens laboratory).  Therefore an increase 
in number of peptides detected is likely to increase the number of phosphorylation sites identified.   
All of the detected peptides were screened against the BimA protein and the bioinformatics analysis 
predicted 4 sites from these peptides to be phosphorylated; S135, T145 and S171.  1 out of 3 predicted 
phosphorylated sites in these peptides was identified in the CD32-BimA sample.  The peptide 
LSAELQNNPR contained a phosphorylated Serine at position 135 in the BimA amino acid sequence. 
This phosphorylation site is located in one of the three WH2 domains and could be involved in the 
recruitment of actin and actin-binding proteins. These WH2 domains have been shown to be 
important for actin binding (Sitthidet et al. 2011) and shown to be able to mimic Ena/Vasp proteins by 
nucleating and elongating actin filaments (Benanti et al. 2015). The identified phosphorylation site 
could be phosphorylated by a host cell kinase to regulate the binding of actin and affect actin-based 
motility of B. pseudomallei. Phosphorylation mutants could be generated from this particular site to 
create a phospho-null and phospho-mimic mutant and investigate the affect on actin-based motility.   
The bioinformatics analysis predicted 4 potential host cell kinases that could phosphorylate S135; PKC-
γ, PKA, ROCK1 and PAK4. PKC-γ is a member of the Protein kinase C family which plays a role in signal 
transduction by regulating neuronal receptors and its main tissue distribution is in the brain (Wetsel 
et al. 1992).  B. pseudomallei is known to cause infection in the brain (Padiglione et al. 1996) and a 
host cell kinase specific to that tissue could be important in regulating the actin-based motility in such 
cell types. Cyclic-AMP (cAMP)-dependent protein kinase (PKA) is the main effector of cAMP signalling 
in all tissues and therefore has a ubiquitous tissue distribution (reviewed in Berthon et al. 2015). This 
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signalling pathway plays an essential role in the regulation of cortisol secretion (reviewed in Berthon 
et al. 2015). PKA has also been shown to regulate the bacterial factor IcsA in Shigella to effect the cell-
to-cell spread (D’Hauteville and Sansonetti 1992).  
ROCK-1 is involved in many types of cell motility such as: smooth-muscle contraction, cell migration 
and neurite outgrowth (reviewed in Riento and Ridley 2003). It is key regulator of the actin 
cytoskeleton and ubiquitously expressed (reviewed in Riento and Ridley 2003). ROCK-1 has been 
shown to phosphorylate and activate formins leading to the formation of stress fibres (Takeya et al. 
2008). BimA is thought to mimic Ena/Vasp proteins which polymerise actin in a similar way to formins. 
ROCK-1 is a kinase that could phosphorylate BimA in a similar way as it does to formins.  PAK 4 is also 
ubiquitously expressed and has a wide role in signalling pathways such as: cytoskeleton regulation, 
cell migration, growth, proliferation and cell survival (Ha et al. 2015).  
Cells infected with B. pseudomallei could also be treated with inhibitors for these kinases and may 
show reduced actin-based motility if phosphorylation by the kinase is important. Inhibitors have been 
developed and studied for ROCK1 and PAK 4 (Liao et al. 2009) (Abdel-Magid 2015). The experiment 
would need to be optimised as these host kinases have important roles for the cell and treatment with 
too high a concentration of inhibitor could be toxic to the cell. An alternative experiment for analysing 
the effect of host cell kinases on B. pseudomallei actin-based motility would be to use siRNA to 
knockdown expression of the kinase. This method has been used to show the importance of CK2 
phosphorylation on the actin-based motility in Listeria (Chong et al. 2009).      
This experiment has shown that CD32-BimA can be expressed by HeLa cells and phosphorylated by a 
host kinase. CD32-BimA is a single monomer of 60kDa whereas native BimA forms a trimer at 180kDa. 
This difference in structure could have an effect on phosphorylation of BimA and this may affect the 
binding of a host cell kinase or which sites are exposed for phosphorylation. CD32-BimA is a fusion 
protein and only BimA would be normally expressed in a B. pseudomallei infection. This difference in 
structure could also affect which sites are phosphorylated. The identified phosphorylation site has 
been identified from BimA protein that was phosphorylated in an uninfected cell. During infection it 
is possible that the host cell processes may well be different and this could affect the phosphorylation 
of proteins.  
To determine if phosphorylation of the identified site is important to B. pseudomallei actin-based 
motility, phosphorylation mutants could be generated. A phospho-null and phospho-mimic mutant 
could be generated and then expressed in trans in a bimA mutant as a trimer in B. pseudomallei. Cells 
could be infected and analysed for actin-based motility. Any difference seen in actin tail formation, 
length or structure would indicate that this phosphorylation site is important to actin-based motility. 
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Further studies could then be done to look at virulence of the phosphorylation mutants.  A Galleria 
mellonella model could be used as an initial infection model before using a mouse model. For both 
models the effect of phosphorylation mutants on survival would be investigated. Infection models for 
B. pseudomallei have been well established and many studies have used them (Laws et al. 2011) 
(Wand et al. 2011).  
In addition to phosphorylation there are other protein modifications that occur in the cell to affect 
protein function. Glycosylation, farnesylation and acetylation are examples of protein modifications 
that could affect the function of BimA. Mass spectrometry of the same immunoprecipitated sample 
of CD32-BimA could look for these other modifications which could then be analysed further by 




















In vitro kinase reaction GST-BimA  
Phosphorylation sites of a protein can also be identified by in vitro kinase reactions where specific host 
cell kinases can be studied. CK2 was used because it has previously been shown to phosphorylate 
Listerial bacterial factor ActA and regulates its actin-based motility (Chong et al. 2009). It is predicted 
to phosphorylate BimA and been shown by Jo Stevens to phosphorylate a GST-BimA fusion protein 
(unpublished data). GSK3, another prominent kinase that was predicted to phosphorylate BimA was 
also studied. GST-BimA was used as a template for in vitro kinase assays because a high concentration 
could be obtained from the E. coli engineered to express the protein. GSH-agarose was used to purify 
GST-BimA and GST from bacterial cell lysates. The purified protein was then analysed by SDS-PAGE 
and SimplyBlue staining (shown in Figure 18). The correct size band of GST-BimA was seen at 68 kDa 
and GST at 28 kDa. The results show a high concentration of GST-BimA and GST purified with only 
1/100 of the sample loaded onto the gel.  
 
Figure 18: Simplyblue stained gel of purified GST and GST-BimA    
Gel shows a Simplyblue stain on purified GST-BimA and GST that was bound to the beads. Arrows point to correct 





Mass spectrometry of in vitro kinase reaction of GST-BimA 
The GST-BimA protein was eluted and concentrated to 3 mg/ml. 60 µg of the sample was incubated 
with commercially available CK2 and GSK3 before being analysed on a phostag gel. Phostag is a novel 
selective phosphate-binding tag used for detection of phosphorylated proteins in SDS-PAGE. During 
electrophoresis, phosphorylated proteins migrate through the gel and are labelled with the phostag. 
Migration speed decreases as they are separated from the non-phosphorylated proteins resulting in 
a mobility shift.  This gel was Simplyblue stained and showed a mobility shift in the phosphorylated 
GST-BimA by both CK2 and GSK3 (data not shown). No mobility shift was seen for GST when incubated 
with CK2 or GSK3. The bands were excised and sent for mass spectrometry analysis at Dundee Cell 
Products shown in Figure 19.  
 
Figure 19: Mass spectrometry of in vitro kinase reaction of GST-BimA 
Figure shows the expected peptides of a trypsin digest of GST-BimA as predicted by ExPASY peptide cutter. In 
red are the actual peptides detected by mass spectrometry. A) Shows GST-BimA peptides phosphorylated by 
CK2 B) shows GST-BimA peptides phosphorylated by GSK3.   
 




























The analysis shows that 43 out of 68 tryptic peptides (60 % coverage) GST-BimA treated by CK2 and 
37 peptides (50 % coverage) GST-BimA treated by GSK3 were detected by mass spectrometry. There 
was a higher coverage of protein detected than from the immunoprecipitated CD32-BimA sample. 
This is likely to be because there was a higher concentration of GST-BimA present in the sample 
compared to CD32-BimA. Clear Simplyblue stained bands were seen on a protein gel for GST-BimA 
whereas a more sensitive silver stain had to be used to show a CD32-BimA band. The 
immunoprecipitated CD32-BimA sample would have contained many other host cell proteins and they 
may have been detected instead of CD32-BimA peptides.  
Peptides from both GST and BimA were identified however no phosphorylation sites were identified. 
The peptides that were detected from the CD32-BimA sample were also detected in the GST-BimA 
samples suggesting these are the peptides the mass spectrometer can detect from a trypsin digest. 
Both kinases are predicted to phosphorylate BimA in the PDAST repeat region which was not detected. 
Only one of the peptides detected was predicted to be phosphorylated by GSK3 so it is perhaps 
unsurprising to see that phosphorylation was not detected. A repeat of the in vitro kinase assay should 
be done and complimentary mapping should be used to provide better coverage of the GST-BimA 
protein. This would involve multiple digestions of the protein with different enzymes e.g. 
trypsin/chymotrypsin/AspN/V8 to generate the correct peptides for mass spectrometry analysis. 
Settings for the instrument may need to be adjusted so that the peptide could be detected and the 
phosphorylation reaction may also need to be optimised.  
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Alternative kinases from the prediction could be investigated to see if they phosphorylate BimA. Once 
phosphorylation of BimA has been detected by mass spectrometry, the phosphorylated protein could 
be investigated further in an actin-pyrene polymerisation assay (Cooper et al. 1983). This assay 
involves the fluorescence of pyrene-conjugated actin that occurs during polymerization and has been 
used in studies before for GST-BimA (Stevens et al. 2005) (Sitthidet et al. 2011). Differences in actin 





















Chapter 4: Investigation of the role of predicted CK2 phosphorylation sites on 
BimA-mediated actin-based motility 
 
Generation of a B. thailandensis BimA mutant 
The closely related avirulent soil saprotype B. thailandensis has been categorised by the Advisory 
Committee on Dangerous Pathogens (ACDP) as a hazard group 1 microbe compared to B. pseudomallei 
which is categorized as a hazard group 3. It has been used a model for B. pseudomallei in many studies 
(Haraga et al. 2008) (Sarkar-Tyson et al. 2009).  
To generate a bimA mutant, PCR-Ligation-PCR mutagenesis (Based on the method described by Ali 
and Steinkasserer 1995) was attempted to amplify the flanking regions of the bimA gene, ligate them 
together and then amplify the ligation product (Figure 21). The plasmid and insert would be cut by 
restriction enzymes to create sticky ends before ligation. This product could then be cloned into the 
suicide vector pDM4 which contains the sacBR genes conferring sucrose sensitivity. The resulting 
plasmid could then be transformed into E. coli before being conjugated with B. thailandensis. 
Homologous recombination would then take place, thereby generating a merodiploid where the 
plasmid would integrate into the genome (Figure 22). Strains would next be selected by sucrose-
resistance due to the loss of sacBR, indicating that the suicide vector had been excised. Colony PCR 
would be performed to identify whether the colonies are either wildtype or a ΔbimA mutant.  
 
Figure 21: PCR-Ligation-PCR method  
Figure shows the PCR-Ligation-PCR method. Flanking sequences of 
bimA were amplified by primers P1, P2, P3 and P4 to generate P1P2 
and P3P4. These two fragments would then be phosphorylated and 








Figure 22: Homologous recombination in B. thailandensis 
Method for allele replacement mutagenesis. Conjugation of the deletion construct into B. thailandensis would 
allow for homologous recombination to occur. The resulting merodiploid strain would be selected for 
chloramphenicol resistance and would be sucrose-sensitive due to the presence of sacBR. Excision of the 
integrated suicide vector from the genome results in either: generation of a deletion strain; or conversion back 
to wild-type. Strains are selected by sucrose-resistance due to the loss of sacBR, indicating that the suicide vector 












Expression of mutant phospho BimAps proteins in a B. thailandensis BimA mutant would allow analysis 
of infected cells by real time microscopy. This would provide much more detailed analysis of the 
mechanism of BimA-mediated movement compared to still images obtained from the Hazard Group 
3 B. pseudomallei strain.   
 
Generation and ligation of flanking sequences 
A yield of 2 µg/µl of B. thailandensis (E30 strain) genomic DNA was obtained by CTAB extraction. This 
DNA was used as a template for generating the flanking sequences and as a wildtype control when 
screening for the mutant. The flanking sequences of bimA, P1P2 and P3P4, were successfully 
generated by PCR at the correct size bands of 413 bp and 510 bp (Figure 23). Both were then 
phosphorylated and ligated however the ligation product of 929 bp could not be amplified using the 
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flanking primers P1 and P4. The B. thailandensis genome is GC rich so the reagents DMSO and high GC 
rich buffer were tried to generate the P1P4 product. A low concentration of around 40 ng/µl was 
obtained for P1P2 and P3P4 and could be why the fragments did not ligate efficiently, hence no P1P4 
product following PCR. Repeat PCR of the fragments to achieve a higher concentration of P1P2 and 
P3P4 would increase the chances of ligation. Redesigning the primers may also improve the yield of 
fragments.  
 
Figure 23: Generation of flanking sequences 
Figure shows the correct band sizes of the flanking sequences of BimA. A) P1P2 =429 bp and B) P3P4 = 516 bp. 
B. thailandensis genomic DNA was amplified using primer pairs P1 + P2 (A), P3 + P4 (B). The resulting products 
were visualised by agarose gel electrophoresis.  
 
 
Subcloning P1P2 into pGEMT 
To improve ligation of the fragments, subcloning each individually into the vector pGEMT was 
attempted. By cloning them into a vector it would be easier to replicate and generate more DNA than 
by PCR. The fragment was cloned by A-tailing and then ligating into the vector before transformation 
into E. coli. Despite recovery of colonies on selective agar, restriction digests showed that there was 
no insert in the plasmid (data not shown). EcoR1 was used as a restriction enzyme to cut the plasmid 
at the A overhangs where the insert was ligated. A high transformation efficiency was obtained of 1.5 
X 108 cfu / µg DNA using a transformation control of pUC18. It is unlikely therefore that the problem 
was with the E. coli transformation efficiency but because of a problem cloning the insert into the 
plasmid. It is possible the Taq polymerase was not able to A-tail the fragments and could be why there 
53 
 
was no insert in the plasmid. A different polymerase could be used for A-tailing and may improve the 
efficiency of ligation into the vector step.  
 
Cloning P1P2 into pDM4 
Direct cloning of P1P2 into the vector pDM4 was also tried by using restriction enzymes and ligating 
the sticky ends. Restriction digests of possible pDM4 bimA plasmids showed only cut plasmid and not 
the expected P1P2 band at 413 bp (Figure 24). A single enzyme control was also performed for the 
same conditions and showed that both enzymes were able to cut pDM4 (data not shown). One 
possibility for a lack of insert in the plasmid could be that it is ligating back on itself. Other 
combinations of restriction enzymes could be tried to see if this improves the ligation of the insert 
into the vector. Inclusion of a phosphatase step to dephosphorylate the vector could be used to 
prevent re-ligation.   
 
Figure 24: Restriction digest of pDM4-P1P2  
 
Figure shows restriction 
digests of pDM4-P1P2 from 
independent colonies 1-5. 
Xba1 and Xho1 were used as 
restriction enzymes at 37°C 
for 4 hrs. A cut plasmid 
control and an uncut plasmid 
control were used.  
 
The generation of pDM4 containing a B. thailandensis bimA deletion construct was proving difficult to 
generate and in the interests of time an alternative strategy was attempted to generate a B. 
thailandensis bimA mutant.   
A pDM4 bimA mutant plasmid (based on B. pseudomallei sequences) has previously been generated 
by Charles Vander Broek. The genomes among the Burkholderia species are very similar and the bim 
locus is highly conserved at the nucleotide level except for the bimA gene which is divergent. Any 
phenotype demonstrated by the bimA mutant could be checked by expressing BimA back in trans. 
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This would ensure the phenotype is a result of bimA deletion. The existing pDM4-BimAps has been 
used to generate unmarked deletion mutants in two B. pseudomallei strains. It should be possible to 
make a B. thailandensis ΔbimA mutant because of the high similarity in sequence of the flanking 
regions and two groups have previously described a similarly-constructed mutant (Benanti et al. 2015) 
(French et al. 2011).  
 
Resistance of B. thailandensis strains 
Different B. thailandensis strains were cultured on selective media containing kanamycin and/or 
chloramphenicol to identify a strain that could be used for conjugation with E.coli S17-λ pir with the 
existing pDM4-BimA plasmid. The strain needed to be resistant to kanamycin so it could be selected 
specifically for B. thailandensis and not the donor E.coli strain. The strain would also need to be 
susceptible to chloramphenicol so colonies would only grow when B. thailandensis contained the 
pDM4-BimA plasmid as it encodes chloramphenicol resistance. Table 1 shows the results of the 
selection. Strains Bp9, BpG488, Bp69 and E30 showed the correct selection (Kanr and Cms).  
 
Table 1: Resistance of B. thailandensis 
Table displays the growth of different B. thailandensis strains on LA plates containing either kanamycin, 
chloramphenicol or both. R indicates resistant, S indicates susceptible. In red are the identified strains suitable 
for conjugation studies.  




Chloramphenicol  + 
Kanamycin 50 µg/ml 
Bp4 R S S S 
Bp9 R S R S 
BpG1190 R S R R 
BpG488 R S R S 
Bp69 R S R S 







Conjugation of B. thailandensis and E.coli S17-λ pir pDM4-bimA 
B. thailandensis E30 and BpG488 strains were conjugated with E. coli S17-λ pir pDM4-bimA and plated 
out on selective plates then incubated at 37 ˚C for 2 days. An S17-λ pir control showed that the plates 
were selective because only 2 colonies grew compared to the conjugated strains. 120 colonies grew 
for B. thailandensis E30 conjugated with S17-λ pir and 14 colonies grew for B. thailandensis BpG488 
conjugated with S17-λ pir.  
 
PCR screening for bimA mutant 
Putative merodiploids were then PCR screened to detect insertion of the plasmid. None of colonies 
for BpG488 showed the correct size band for a mutant. A negative control was used which contained 
all reagents used for the PCR reaction except for template DNA to ensure no contaminants would be 
amplified. A wildtype B. thailandensis genomic DNA template (E30) was used as another negative 
control which would give an expected band size of 2039 bp. This is because the primers would amplify 
the flanking regions and bimA gene. The expected band size for the pDM4-bimA P1P4 sequence was 
at 539 bp with just the flanking regions being amplified. Initially the PCR screen had to be optimised 
by adjusting the annealing temperature and DMSO was used for the controls to show the correct band 
sizes. DMSO helps separate the DNA strands by disrupting base pairing. Using the optimised PCR 
conditions E30 colonies were screened and one showed the correct size band of 539 bp which was 
taken forward for sucrose selection. Figure 25 shows the potential mutant identified and the correct 
band size for wildtype control. Additional bands can be seen on the gel suggesting the primers are not 
specific enough. Redesigning of the primers or further optimisation of the PCR conditions would 











Figure 25: PCR screen of selected colonies from conjugation of E30 and S17-λ pir pDM4-bimA 
Figure shows an agarose gel of the PCR screen to detect insertion of the plasmid into B. thailandensis. Two 
negative controls were used shown in the first two lanes: negative control where no template was added, WT 
control is B. thailandensis genomic DNA. The remaining lanes are colonies from conjugation. Arrow points to the 




Sucrose selection of potential bimA mutant  
The potential merodiploid colony was grown overnight in the absence of selection then plated out 
onto sucrose plates and incubated at 30 ̊ C for 2 days. The plasmid pDM4 contains a SacBR gene which 
when expressed is toxic to the bacteria when grown in the presence of sucrose (Logue et al. 2009). 
This provides direct selection for loss of the plasmid and when it excises it can either delete the 
Wildtype gene or the mutated one. 
137 colonies grew on the sucrose plates. These colonies were then PCR screened and 3 showed the 
correct size band of 539 bp for a bimA mutant. To confirm these colonies were mutants, HeLa cells 
were infected with the potential mutants before being analysed by immunostaining for B. 
thailandensis, actin and nuclei and imaged by confocal microscopy. The analysis showed that all three 
potential mutants displayed actin tails and therefore bimA had not been successfully deleted. A B. 
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thailandensis bimA mutant would not be able to form actin tails and the correct band sizes seen for 
the potential mutants were false positives. It is very common for colony PCR screening to show false 
positives and any contamination in the PCR reaction can lead to the appearance of an aberrant band. 
To increase the selection for a mutant, 2 sets of primers could be used for each colony. One could be 
used to amplify the total insertion and another to amplify a sequence within the insertion. A second 
PCR screen could then be used to remove any false positives identified in the first screen. It is also 
possible that B. thailandensis does not recombine with the plasmid because it is recognised by the 
bacteria as being foreign DNA.  
The generation of a B. thailandensis bimA mutant has previously been demonstrated and its role has 
been investigated in actin-based motility (French et al. 2011) (Benanti et al. 2015). Although 
generation of the B. thailandensis-specific suicide plasmid by PCR-Ligation-PCR mutagenesis has been 
unsuccessful, studies by French et al (2011) have generated bimA mutants by this method. Studies by 
Benanti et al 2015 have generated a bimA mutant by an alternative method. This involves construction 
of multiple plasmids for allelic exchange and could be used as further work to generate a B. 
thailandensis bimA mutant for this project (Lopez et al. 2009). However for this study a different strain, 















Effect of mutation of predicted CK2 phosphorylation sites on BimA-mediated 
actin-based motility  
 
Many potential phosphorylation sites of BimA were identified by the bioinformatics analysis and one 
particular region predicted to be phosphorylated was the PDAST repeat region. This region varies in 
number between 2-7 motifs and studies have previously shown that the number of PDAST motifs 
affected the polymerisation of actin in an additive manner (Sitthidet et al. 2011). This repeat region 
contains many Serines and Threonines which are common targets for phosphorylation. The 
bioinformatics analysis predicted these amino acids to be phosphorylated by CK2 and GSK3. It is 
possible that actin polymerisation mediated by BimA could be affected by phosphorylation in the 
PDAST repeat region and previous work has shown CK2 could phosphorylate GST-BimA (unpublished 
data from the Stevens laboratory). BimA phosphorylation mutants were generated to investigate the 
effect of phosphorylation of Serines in the PDAST repeat region, Figure 26. Serines were chosen in this 
region because they are predicted to be phosphorylated by CK2, a kinase that is known to affect the 
actin-based motility of other intracellular pathogens. As the generation of a B. thailandensis bimA 
mutant had been unsuccessful, a B. pseudomallei bimA mutant was used to express the BimA 
phosphorylation mutant proteins.  
 
Figure 26: Schematic of mutated proteins 
Figure shows the PDAST repeat region sequence for Wildtype (BimA), Phospho-null mutant (BimA S/A) and 
Phospho-mimic mutant (S/D). In red are the mutated Serine residues at positions 260, 265, 270 and 275. For the 
phospho-null mutant Serine residues have been mutated to an Alanine and for the phospho-mimic mutant 
Serines have been mutated to an Aspartic acid residue.  
 
 
To generate the phosphorylation mutants, Serine residues at positions 260, 265, 270 and 275 in pME-
BimA were mutated to Alanines for phospho-null and to Aspartic acids for phospho-mimic. The pME-
BimA plasmid has previously been generated (Stevens et al. 2005). The mutant plasmids were then 
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transformed into a B. pseudomallei ΔbimA mutant. This would ensure no homogenous BimA would 
also be expressed. A ΔbimA mutant was complemented with pME-BimA as a control and compared to 
a wildtype strain. A ΔbimA mutant was also complemented with pME as a negative control. Serines 
within the target PDAST repeat region of pME-BimA were mutated to Alanines for a phospho-null 
mutant. Therefore, when the plasmid is expressed in B. pseudomallei the BimA protein would not be 
phosphorylated at these sites. A phosphorylation mimic was also generated by mutating the Serines 
to Aspartic acids so when the plasmid is expressed the BimA protein will mimic constitutively 
phosphorylated sites. Expression of BimA was confirmed in the phosphorylation mutant strains before 
they were then observed in HeLa cells and analysed for differences in actin-based motility. Strains 
containing the plasmid pME were grown with tetracycline to select specifically for bacteria 
transformed with the plasmid. IPTG was used to induce expression of the plasmid pME.  
 
Expression of BimA in Phosphorylation mutants 
B. pseudomallei ΔbimA mutants transformed with either pME-BimA, pME-BimA S/A or pME-BimA S/D 
showed expression of BimA by western blot of lysates at 20 hours and confirmed transformation of 
the plasmids was successful (shown in Figure 27). The correct size band of 180 kDa was seen for BimA 
in the lysates of pME-BimA, pME-BimA S/A and pME-BimA S/D (Figure 27). BimA was absent from the 
Wildtype bacterial lysate because it does not express BimA in LB broth as it is tightly regulated by 
VirAG but will express it in a cell lysate (Chen et al. 2011). BimA is a trimeric protein and therefore has 
a molecular weight three times 60 kDa. Negative controls used were Wildtype B. pseudomallei (WT), 
B. pseudomallei BimA mutant (ΔBimA) and B. pseudomallei pME (pME).  
 
Figure 27: Western blot of B. pseudomallei lysates 
B. pseudomallei ΔbimA mutants carrying pME, pME-bimA, pME-bimA S/A and pME-bimA S/D were grown in LB 
broth containing tetracycline and IPTG. At 20 hrs bacteria were lysed with bugbuster and lysates were run by 
SDS-PAGE before western blot. A) Proteins detected by incubation with anti-BimA followed by anti-mouse 680 





Infection of HeLa cells with BimA phosphorylation mutants 
HeLa cells were seeded onto coverslips and infected with B. pseudomallei before being fixed at 20 
hours post-infection. The coverslips were stained for B. pseudomallei, BimA and nuclei before being 
imaged by confocal microscopy to investigate the effect on BimA localisation. Results can be seen in 
Figure 28 with all strains except ΔbimA displaying polar localisation of BimA at a single pole of the 
bacterium. Duplicate coverslips were also stained for B. pseudomallei, actin and nuclei before being 
imaged by confocal microscopy to investigate the effect on actin tail formation. Results can be seen 
in Figure 29. B. pseudomallei ΔbimA transformed with pME-BimA, pME-BimA S/D and pME-BimA S/A 
all demonstrated actin tails whilst the pME ΔbimA alone strain did not.  
 
Figure 28: BimA localisation of phosphorylation mutants 20 hours after infection in HeLa cells  
Confocal microscopy images of HeLa cells 20 hours after infection with B. pseudomallei ΔbimA mutants carrying 
pME-bimA, pME-bimA S/A and pME-bimA S/D.  Coverslips were fixed in paraformaldehyde before being 
permeabilised with Triton X 100. Coverslips were stained with anti-LPS followed by anti-rabbit 568, anti-BimA 
followed by anti-mouse 488 and DAPI. Blue channel – nucleus, red channel – B. pseudomallei and green channel 
– BimA. A) Control, infection with B. pseudomallei containing pME-BimA. B) Phospho-mimic, infection with B. 
pseudomallei containing pME-BimA S/D. C) Phospho-null, infection with B. pseudomallei containing pME-BimA 
S/A.  








Figure 29: HeLa cells 20 hours after infection with BimA phosphorylation mutants 
Confocal microscopy images of HeLa cells 20 hours after infection with B. pseudomallei ΔbimA mutants carrying 
pME, pME-bimA, pME-bimA S/A and pME-bimA S/D. Coverslips were fixed in paraformaldehyde before being 
permeabilised with Triton X 100. Coverslips were stained with anti-LPS followed by anti-mouse 568, Phalloidin 
and DAPI. Blue channel – nucleus, red channel – B. pseudomallei and green channel – actin. A) Control, infection 
with B. pseudomallei containing pME-BimA. B) Control, infection with B. pseudomallei containing pME. C) 
Phospho-mimic, infection with B. pseudomallei containing pME-BimA S/D. D) Phospho-null, infection with B. 
pseudomallei containing pME-BimA S/A.  
A) pME-BimA - Control 
Blue channel - Nuclei    Red channel – B. pseudomallei 
    




B) pME - Control 
Blue channel - Nuclei      Red channel – B. pseudomallei 
 
 







C) pME-BimA S/D – Phospho mimic mutant 
Blue channel - Nuclei     Red channel – B. pseudomallei 
 










D) pME-BimA S/A – Phospho null mutant 
Blue channel - Nuclei      Red channel - B. pseudomallei 
 
 








Figure 28 shows that for pME-BimA, pME-BimA S/D and pME-BimA S/A the BimA protein is localised 
to the pole of the cell. This is where BimA is expressed in wildtype B. pseudomallei and the position at 
which the actin tail forms. It is possible that mutations in the amino acid sequence of BimA could affect 
the structure of the protein. A change in structure could potentionally display a different localisation 
of BimA. However phosphorylation of Serines in the PDAST repeat region has been shown not to have 
an effect on localisation of BimA. Some bacteria are not showing BimA present and this could be 
because they have lost the plasmid since they are cultured in the absence of tetracycline during the 
infection experiment.  
Analysis of the confocal microscopy images showed there to be no obvious effect on actin tail 
formation with both the phospho-null and phospho-mimic displaying actin tails similar to the control. 
Studies in Listeria have shown that a phospho-null mutant was unable to form actin tails (Chong et al. 
2009). It was thought that the phospho-null mutant in B. pseudomallei would function similarly and 
not be able to form actin tails if phosphorylation of the Serines in the PDAST repeat region was 
important to tail formation. Further repeats are needed to confirm this result and also further studies 
investigating the number of B. pseudomallei with a tail. Some bacteria transformed with pME-BimA 
do not display a tail and it is likely these are bacteria not expressing BimA seen in Figure 29A, C and D. 
No tails were seen for B. pseudomallei transformed with pME as it does express a bimA gene. Without 
BimA the bacteria are unable to form an actin tail, seen in Figure 29B. The actin tail allows for bacteria 
to display intracellular motility and they can be seen spaced out within the cell cytosol which is as seen 
in Figure 29A, C and D. However as the pME mutant does not form a tail it cannot move inside the cell 
and therefore the bacteria are all very close together as seen in Figure 29B.  
An earlier time point in infection could also be investigated. It is possible that phosphorylation may be 
important to the rate of tail formation and affect the rate of the B. pseudomallei life cycle. 
Phosphorylation of Serines in the PDAST repeat region may not have an effect on tail formation but 
could have an effect on actin-based motility by regulating actin tail length and structure. The structure 
of the tail for B. pseudomallei can be seen in Figure 29 with many bacteria displaying a helical spiral 
structure in agreement with Benanti et al 2015. Phosphorylation of sites in the BimA protein could be 
important to regulating this spiral structure and further studies should look at the difference between 
types of tail for phosphorylation mutants.  
Results showed that phosphorylation of the Serines in the PDAST repeat region had no effect on actin 
tail formation or localisation of BimA. However, it is possible though that phosphorylation of Serines 
could have an effect on regulating the actin tail length. Therefore, an analysis was performed on 
multiple to calculate the average actin tail length. The actin tail area was selected and tail length was 
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measured using Image J software to calculate the Feret’s Diameter. This value is the longest distance 
between any two points along the selection boundary and is also known as the maximum calliper. 100 
actin tails in total were measured from each strain from three biological replicates. Results are shown 
in Figure 30 and showed only a small increase in average tail length of pME-BimA S/D and pME-BimA 
S/A compared to the wildtype but not statistically significant. Unpaired Student’s t tests were 
performed and showed a two-tailed P value equal to 0.7813 (pME-BimA and pME-BimA S/D) and 
0.7130 (pME-BimA and pME-BimA S/A). All mutant strains had an average tail length between 5-5.5 
µm. Studies by Benanti et al. 2015 have shown longer tails around 15 µm for the wildtype B. 
pseudomallei. The difference in tail length could be because wildtype B. pseudomallei was used 
instead of a pME-BimA strain or because different cell types, A459 and Cos7, were used. Different 
phenotypes might be cell-type specific as many kinases have restricted cell and tissue expression. 
Additional experiments could be performed in A459 and Cos7 to analyse the effect on actin tail length 
of the phosphorylation mutants.  
Some variation in tail length was observed from images taken in Figure 29 and analysis shown in Figure 
30. This variation in tail lengths is likely to be because of bacteria being at different stages of their life 
cycles. To improve the reliability of results a higher number of actin tails could be measured which 
may allow for a difference to be observed between the mutants. 500 actin tails could be measured 
compared to 100. Z-stacks were taken to account for all planes of the confocal microscope and made 
sure the whole of the actin tail was measured and not just part of a tail on one plane.  
The actin density of the tail could also be studied by measuring the intensity of the fluorescence of 
the tail. Phosphorylation mutants may not affect the tail length but could be important in regulating 











Figure 30: Tail length of phosphorylation mutants 20 hrs after infection in HeLa cells 
Figure shows the average Feret’s diameter of actin tails for B. pseudomallei ΔbimA mutants carrying pME-bimA, 
pME-bimA S/D and pME-bimA S/A.  Analysis was performed on confocal microscopy images and the data 
represents 100 actin tails in total from 3 biological replicates for each mutant with standard error bars.  
 
 
Results from this study do not show a difference in actin-based motility between the pME-BimA, pME-
BimA S/D and pME-BimA S/A mutants. Confocal microscopy images have shown actin tail formation 
and BimA localisation to be the same as the control. Further studies into actin tail length was also not 
able to show a difference between the phosphorylation mutants and pME-BimA strain. These results 
suggest phosphorylation of Serines in the PDAST repeat region is not important for actin-based 
motility however further studies should investigate the number of bacteria with a tail, tail structure 
and tail density.  
The PDAST repeat region contains many Threonines which are predicted as common targets for 
kinases and could be phosphorylated to affect the actin-based motility of B. pseudomallei. Further 
studies should be done to generate BimA phosphorylation mutant proteins where Threonines are 
substituted in the PDAST repeat region which could display differences in actin tail formation. 
Phosphorylation of Threonines and not Serines could be a reason for the additive effect in actin 
polymerisation of the PDAST repeat region seen in previous studies (Sitthidet et al. 2011). It is possible 
that the additive effect is not due to modification of the amino acids but only a difference in structure 
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and the number of motifs effects the actin polymerisation through altered 2˚ structure of BimA rather 
than phosphorylation of the protein.   
 
Intracellular survival of HeLa cells with BimA phosphorylation mutants 
An observation from the confocal microscopy was that there was a difference in number of bacteria 
for the phospho mimic and suggested phosphorylation could have a role in intracellular replication 
rate. To investigate this HeLa cells were infected at a Multiplicity Of Infection (MOI) of 200 with 
phosphorylation mutants and at 20 hours cells were lysed and dilutions plated and incubated at 37˚C 
for 2 days. Figure 31 shows the total CFU/well for each strain at 20 hours. An infection inoculum was 
also calculated of around 4 X 106 CFU/ml for each strain.  
 
Figure 31: Bacterial load of B. pseudomallei ΔbimA mutants in HeLa cells 20 hours after infection.  
Figure shows the CFU/well 20 hours after infection of HeLa cells with B. pseudomallei 10726 and ΔbimA mutants 
carrying pME, pME-bimA, pME-bimA S/A and pME-bimA S/D.  The data represents 3 biological replicates with 3 






The analysis shows the bacterial load of 1 X 105 CFU/well of HeLa cells for wildtype, pME-BimA and 
pME-BimA S/A at 20 hours after infection. This is less than the infection inoculum and could be 
because B. pseudomallei has a very low invasion rate and very few bacteria are able to enter HeLa 
cells or because they are killed. The pME-BimA S/A mutant showed the same CFU/well as pME-BimA 
suggesting phosphorylation of Serines in the PDAST region is not important to intracellular survival of 
B. pseudomallei. There was a small decrease in CFU/ well for the pME-BimA S/D compared to pME-
BimA however it was not statistically significant. An unpaired Students t test was performed and 
showed a two-tailed P value equal to 0.1614. The decrease in CFU/ well for pME-BimA S/D may have 
been observed as a result of a change in structure of the BimA protein because actin-based motility 
appears to be the same as shown in Figures 28, 29 and 30. Most proteins have specific binding motifs 
and the Aspartic acid residues which have replaced Serines could affect the proteins binding to BimA 
by changing the structure of this region. A difference in the binding of proteins to BimA could affect 
the survival of B. pseudomallei in the host cell.  
It is also possible that any regulation by host cell kinases needs to be tightly regulated. A mutant that 
is constantly phosphorylated may hinder the bacteria. Studies in Listeria have shown the importance 
of phosphorylation of ActA to actin-based motility (Chong et al. 2009). However a phospho mimic 
mutant showed defective cell-to-cell spread and a lower survival than the wildtype in a mouse model 
(Chong et al. 2009). This could be similar in a phospho-mimic mutant of B. pseudomallei where the 
lower levels of bacteria seen in Figure 30 are because the phosphorylation site needs to be tightly 
regulated.  
The ΔbimA and pME mutants showed a lower bacterial load of around 2 X 104 CFU/well. An unpaired 
Students t test showed a significant statistical difference between wildtype and ΔbimA, with a two-
tailed P value equal to 0.0070. An unpaired Students t test showed a significant statistical difference 
between pME-BimA and pME, with a two-tailed P value equal to 0.0273.  This result is expected 
because if B. pseudomallei is unable to express BimA, the life cycle would be affected and the 
replication rate reduced.  
Further studies should be done at a later timepoint of 24 hours to create a time course and would be 
able to determine if the mutants can replicate in HeLa cells. This would allow a greater difference in 
CFU/well to be seen between pME-BimA and pME. The pME-BimA S/D mutant has a bacterial load in 
between the pME-BimA and pME strains. At 20 hours the results were not significantly different but 
at 24 hours a statistical difference may be seen if the time course experiment were to be performed. 
This experiment could also be repeated in a macrophage cell line such as J774 where bacteria are 
actively removed by phagosomal degradation. In a macrophage BimA function may be more important 
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to survival of the bacteria than in a HeLa cell and bacteria expressing mutated BimA’s are likely to be 
rapidly cleared. A significant difference might be seen between pME-BimA S/D and pME-BimA under 
these conditions. An additional experiment could be to look at the effect of the phosphorylation 























Chapter 5: Conclusions and Future Perspectives 
Phosphorylation is an important post-translational modification that enhances the function of many 
host proteins and has been shown to be important by modifying some pathogen virulence factors and 
affecting the actin-based motility of some intracellular pathogens. This project investigated the effect 
of phosphorylation of BimA in B. pseudomallei. A combined bioinformatics data analysis on B. 
pseudomallei BimA amino acid sequence predicted the protein could be phosphorylated at 37 
potential sites and identified a number of novel host cell kinases that could be responsible for these 
modifications.  
The PDAST repeat region was predicted to be phosphorylated by host cell kinases and has been shown 
to be important for actin polymerisation (Sitthidet et al. 2011). CK2 and GSK3 were two host cell 
kinases predicted to phosphorylate this region. CK2 is a kinase that is known to regulate pathogen 
factors and affect actin-based motility of Listeria. It has also been previously shown to phosphorylate 
BimA (Stevens, unpublished data). GSK3 was a prominent kinase to come out of the bioinformatics 
analysis and a good candidate for phosphorylation of BimA.  
To identify novel sites of phosphorylation sites of the PDAST repeat region for CK2 and GSK3, in vitro 
kinase assays and mass spectrometry analysis were performed.  However results showed no 
phosphorylation of GST-BimA. Peptide coverage from the mass spectrometry was low and the PDAST 
repeat region was undetected so it is possible there are unidentified sites of BimA phosphorylation. 
Further studies should be done by repeating the in vitro kinase assay and using complimentary 
mapping to provide better coverage of the GST-BimA protein. Settings for the instrument may need 
to be adjusted so that the peptide could be detected and the phosphorylation reaction may also need 
to be optimised. 
Based on the prediction and previous studies on the PDAST repeat region, it was hypothesized that 
phosphorylation of Serine residues in the PDAST region of BimA could affect actin-based motility. To 
investigate this, plasmids encoding mutated BimA proteins were generated.  
As generation of B. thailandensis BimA mutant was unsuccessful, the phosphorylation mutant BimA 
proteins were expressed in a B. pseudomallei ΔbimA strain. B. pseudomallei expressing the phospho-
mimic (BimA S/D) or phospho-null (BimA S/A) mutant BimA’s were able to form actin tails in HeLa cells 
and showed no difference in actin tail length or BimA localisation. This study shows that 
phosphorylation of Serines in the PDAST region were not important for actin-based motility.  The 
PDAST repeat region contains many Threonines which are predicted as common targets for kinases 
and could be phosphorylated to affect the actin-based motility of B. pseudomallei. Further studies 
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should be performed to generate BimA and their phosphorylation mutant proteins where Threonines 
are substituted in the PDAST repeat region and investigated in the same way as the Serine 
phosphorylation mutants. Actin tail formation, BimA localisation and actin tail length should all be 
analysed. Phosphorylation of Threonines and not Serines could be a reason for the additive effect in 
actin polymerisation of the PDAST repeat demonstrated seen in previous studies (Sitthidet et al. 2011).  
Further studies should be performed for the survival of phosphorylation mutants and at a later 
timepoint to create a time course. This would allow any temporal difference between the mutant 
BimA’s and wildtype to be detected. This experiment could also be repeated in a macrophage cell line 
such as J774 where bacteria are actively removed by phagosomal degradation. In a macrophage BimA 
function may be more important for survival of the bacteria than in a HeLa cell and bacteria expressing 
mutated BimA’s are likely to be rapidly cleared. A significant difference might be seen between 
phospho-mimic and wildtype BimA’s under these conditions. 
The bioinformatics analysis predicted BimA to be phosphorylated by host cell kinases at many sites in 
different functional domains. To identify the actual sites a method for transfection of HeLa cells with 
pCD32-BimA and immunoprecipitating this protein has been optimised. Mass spectrometry analysis 
of immunoprecipitated CD32-BimA has identified a novel phosphorylation site, S135. Peptide coverage 
was low and it is possible there are more unidentified sites of BimA phosphorylation. Further 
optimisation of the immunoprecipitation of CD32-BimA and then a repeat mass spectrometry analysis 
using complimentary mapping should be used to provide an improved protein coverage.   
S135 was also one of the sites predicted from the bioinformatics analysis as a target for host cell kinases 
and is located in a WH2 domain. These WH2 domains have been shown to be important for actin 
binding and shown to be able to mimic Ena/Vasp proteins by nucleating and elongating actin filaments 
(Sitthidet et al. 2011) (Benanti et al. 2015). Phosphorylation mutants of this site should be generated 
to analyse the effect on actin-based motility.  Cells could be infected and analysed for actin-based 
motility. Any difference seen in actin tail formation, length or structure would indicate that this 
phosphorylation site is important to actin-based motility. Further studies could then be done to look 
at virulence of the phosphorylation mutants.  A Galleria mellonella model could be used as an initial 
infection model before using a mouse model. For both models the effect of phosphorylation mutants 
on survival would be investigated. Infection models for B. pseudomallei are well established and many 
studies have used them (Laws et al. 2011) (Wand et al. 2011). 
The bioinformatics analysis predicted 4 potential host cell kinases that could phosphorylate S135; PKC-
γ, PKA, ROCK1 and PAK4. Cells infected with B. pseudomallei could also be treated with inhibitors for 
these kinases and may show reduced actin-based motility if phosphorylation by the kinase is 
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important. Inhibitors have been developed and studied for ROCK1 and PAK 4 (Liao et al. 2009) (Abdel-
Magid 2015). The experiment would need to be optimised as these host kinases have important roles 
for the cell and treatment with too high a concentration of inhibitor could be toxic to the cell. An 
alternative experiment for analysing the effect of host cell kinases on B. pseudomallei actin-based 
motility would be to use siRNA to knockdown of the relevant kinase. This method has been used to 
show the importance of CK2 phosphorylation on the actin-based motility of Listeria (Chong et al. 
2009). 
Alternative kinases from the prediction could be investigated to see if they phosphorylate BimA and 
further in vitro kinases assays of GST-BimA should be performed. Once phosphorylation of BimA has 
been detected by mass spectrometry, the phosphorylated protein could be investigated further in an 
actin-pyrene polymerisation assay (Stevens et al. 2005) (Sitthidet et al. 2011). This assay involves 
measuring the emission of fluorescence of pyrene-conjugated actin that occurs during polymerization. 
Differences in actin polymerisation could indicate that phosphorylation of BimA by a host kinase is 
important to actin-based motility.  
The aim of this project was to investigate the effect of host cell phosphorylation of BimA on actin-
based motility of B. pseudomallei. BimA is a protein that is vital for the intracellular motility stage of 
this pathogen. Sites of the PDAST repeat region, predicted to be phosphorylated, have been 
investigated for their effect on actin-based motility. A novel phosphorylation site, S135, has been 
identified by optimising a method for transfection of HeLa cells with pCD32-BimA and 
immunoprecipitating this protein. This method can now be used to immunoprecipitate CD32-BimA for 
further experiments on post-translational modifications. Phosphorylation of S135, could affect the 
function of BimA and has opened up the opportunity for further research. Discovery of novel sites that 
are important to actin-based motility of B. pseudomallei will lead to a better understanding of the 
mechanism of this pathogen’s intracellular life cycle stage. This could lead to the development of novel 
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